Y).+n"3d^D6EFmB>DJf%.YdIA2psF]$
9#:@H"\U/V29S]K9Q%@:h:2RQ%CN&ckY+;L'T5LK$^h73n1j2\%^!jH&mEoi4XD*@
;#66sS'5gf!n#o$:'ko729EQ&5)U(WL6#.X%A`d>==42(`YMAC8*lr3bPP9s_>_
52VKbn-0""#g9A$ZZ`/'m.n?dfB\O/.^HLZH/&
RCP-Fo=\YPEFh?hJ2BW((DsuG^k4[J^%g[2.!:@a[m22uFeM_ahg5"mUN:!O99
lgg&>.2JB31sI[g6!)Yirb.u`pB5/L1bT?J5Sn7Raj@ub3*p^2J9cC#F)hM>(N3I;
m,40Q%@ke%jR1O,0gQegZVK/&L]`(W`-r;sJR.c5feQ&\D+u=*OuC.I"-3,l=5W/JRPr,Jt"C(D@GMD
'Y`S4UGc^R8iY$3N)j/I#h7>2iJ6P:NEPkDGnM9^/(dQQMiXjc>go8m/2'+2hu3/)
A05)F_PYt&ZEY$4(UrVdUcMD#0I5^eYTsE6+.DECC;9rN`fuZ47XZm@#T4I-'AHqRX9!
p_mnFIPJ`cZXj:tK]QTQX_q!%CG9]BTuMJTA2GW$KIV_2^q^-V[iok*dAU8m`)sQJ
2Ad>7)]H3q,4V>C&dMCPI=d+E#Fi$tbulg&]cGf']QB(Xg;Ep]E5/KGk`Hp'Ui
ID*;k>OKS9+heV+R@$&4+l3tid?Xq%q\J]V9`577#k\<"(\Ocj*JBiqU&S`T78jHU
R'*U.F@[4+a:F>!0q2a,-4VjpFTWsOXGK:R04)YrBR8!cjHC#7RoRhH`^bOno)#0:!
^Iuuc23CM"#SqsoKm)=kY.5\Ed\jUjF4i^$0#r]Fg3,G=IG3BMoVkcEXf\q9/MGY0
HXoZ*q&*WqEm/X?6miA!MUK,/&Q'b%[b'l-7Xl@giiB5sb2T%@dm/06GD*ruJ&YsB
YHSCYoE56q(\OF322gg:9G_$1bp449R7`m$i(kLc]_NHD;Hb6:[7L-mmcttY^Q2*A
NTnhE:1M(?SB(K'=4^ELf2Q*Kp[RoJp[o2eI:Je&"/In?HR+WH+jgsc"^,j.f=J1e
+sR;#F0'59S\RKuC<)-?8DPq3R:H#(H]84NRD/2kX5P]Y_368'H8-6Mm;]?iLfp`H
>iqKjNh3@7PhENDTM[]&PE^gra<.(f=D7G^?3QU?3tgm=-0.`-em(WLp\qWZ*+
<1--71fZjZT`Ij-iWHEH'gf8IV@>u!A3:=]M$;H.b)8UV!S`UO?pWc;dIE4C,(D/s
)kc^GqMX3B8*hRrM6Vl2Ll?+LY17j72dTZ7KZQ>-5/S+V&"Y2o4hc@!$%CXNr#Om(
A#]11i'g.Sh@L9iR$/Q.B?.r$7rk3%(+g;\`UCEL+2\7BP_n;(?0&kEKs>m3<>Gh1
o!kAap:\-k*fmhFk/P+d_1VGQ$'%u+l?.e<>L@L'N+D\!8.NAn+=e0/`(2UhlP+gR1k8"$_oi5#bfDVmt0(JO;
_J;l(o(.bHoA_&>j5V@/iq!QJk/H3PqdUL3lK!.D9r+:1fj;_Lh^W=i'7tI=7IZC
>$44r*9N_CO-pZk5dgB7`:`9PPF<0_lG$5d;Wd]'W_R!_^l.TUO5hUm9^N$
DKoOEQJJUTF[LGS(K=[6!;).eZ`2[72fG^f"dE-nXk8aMb0O/MShA>]37cOfIV
_*8M<0gU9G<4'[d*J\SPS=WUV$K>Sf5mcD$s!V,Q;YH!V98J?I"eBghJZK20`4*QL
%N@^Y`a.;%=0$q^l9GYBp%bEI,/2j)/QeFIFK(-GeV#)X?9q)>,'\*tfYMmE;J4MN
F.G9'97BOX8LQ;EI](:Tn=3XdY3lc7XD(GrjralJJK:foq>)K,2[/Rb\G2JQ&8jnl
k6L(a5`+6GC:s-EbT:a3(pI_2)q2Ya@f;/T^L=b^C`X##`5:PKBmDh9'ITXV3Ckru
b]V*tbE7e&MYr4q,aGTI$-X$LfXl@5mW*7\;)j/CCr^udY&aT(,o;UGJo8[#FPrgU
KE%#TC\PPuV0SD_:=n1oHsg-ASWL+DXij`AWKV`G\o5/bX$(X:6,:>k70f^gY$E1%
.EaCgY/Zb--;4lt/Z(i:Hi'PGo?QSH$i,:6)/PQ+Z8d&GlMSdG!PY8D_&r$bJuKj3
"g-a!I=1b!E/Rtbj1L)Z6p[BCW6;C)R$tb+2(l`S)Kl(5&2K(Z%Ku$L[U!1:ceUEu
^![SOc*c+D/@ZmO2[KoGY21Btr,p^U`7K0Xe;5C+3)?PnAZ_Vg6]e8m:kj$*d\'XC+Ia%6'cE]cN4,>u'!je]Ob\kS/Cr"8.Tke\aHIilAF*h^6X]'$
3\dh\T3jL;@ZF\!]loZ!dc<(oNQh9-6J`ZplMI
rs[RsHhfo'T9VAq3j/Luau]H/2a7us`58-IJi-]tl5JotR]g)[>3PU!;.;D5.5Qb=1)SKN+%1T`O#"=iO0?I.?/JU#3*ECjgA/_9rK)]Wq3$H>=Os
koiHu7&W/^A1(&)6Nhc_0FoS#Mska1lP`Oo0,'_p1]9[Ro4A?l=AN0!H\@u[Zo3;!
Alb(VC.>&^([N^9J/d^'nPA;U>94>2'MQrmr/-tl.PN2=NC6N*Qo^A^o"u?DfrdVX
!jk*\aT3(J9KCRb,Q+;Ms+!"V70`g9;-tRNX'+@kYMEt-/h5(@M
MTR&A31)3k+m',IEki"l:rJkNRc,^*d75n!M`dR@@qjtLN)#J]$e$f\@!I8-N&C?(
s3#Z[a#%p-@CinNF=q_2HphYf_kCZPK!$ROW#1Fb#'3.e7JeK0UJSiRU>dq?@$r0X
F/7Led.6It0:?(VjVIA?EtLL/A1"R6'.#j-8Agm+h@3N,`(1]Y'i>\+dPL
o:>?AHS2C3YgL\g^aV63Z9;_3:KE[6b]uE,&/tp3r+$#-ggNGYg:a0K
[N36Iq/KE\+;*_KITS)ia,>L"h"%OTm,qdgrS4q?fM(q%dp@`,[\+!,GksT/=8aC]
0@On0r#']oGZ3p0D6;1rQFi=`Tk_2&L=M(HT;uP@X,``o]:+^q7TJd%%l\>X?>%UI
m0,i(Na:Uu/>ib&U'gUMC=j2ER3T."Y`U=GU;/)g)bc)uLb2`H"mX$6S_Rc%6n01$
L[S'q67UihATpKebj<`nRkUNTOs-+[D'X\iLmrMQe!3HnTS2W=4P*2(;R3__j4@-4
NgBG:?m<%-'?Vtf5__\B9G))n&2(8[,r#A0pt;1;?oN!#cc[dL&Nn+=f=HK`1e_Bt
6h4,8aBL(d?h.>;[\+!t%7MMbQrGWRX
dcr?b59K7=r6mqSpeH85Gg-^uO/VKG7#d^qA"ZpK=T^YuR,WgAYH!;*d^gF7Fh3J^
Q6LXe4$29d:>W$+RE_VI+'1S7hq*(%aQtYOb"?V0_Cm*LQ']A.\9%t?V(`@=i_m#6
^M_g(ZOome&.):ook^!`9FKHi/1fh*_c8g>_#`QUm[ZmNSmE0sa0^-AlY.@/o*X/s
hj0Bohl&2NG`n<+C%m,ifnW3CSPm_HZp\@"K:T>q
hLTTMXY$30Jb>C?:>-:RWc%[RV4@%L7kk2Zgt*
HeQNfi&tZt,T4]pp3?'T.q,bSU'2u$S$b(C%DL^s9e%R1,dh.0&*`2OUmKLGo[5#N
VJF_&sS!n5gG:`4t=;2l#:fEHc3!gobc>ZZkOc<`sV+,p>kmflg
@m(9uI[l1lL*Fes,Z%H0;9lMQ>ksEb@(dPrTG#)6'#C4R_'$>>@Z`JViLF)U:a!jI
_rr-LB'2NA!jn8T`1j>J?sNM2ir$+joue6$6+
(i7^_+F0r.l_Q/p4-??snq\23L4Ffi5XCDc,6'Ae^L$W^.pdP@9
endstream
endobj
41 1 obj
<<
/Type /Font
/Subtype /Type1
/FirstChar 0
/LastChar 255
/Widths [ 250 250 250 250 250 250 250 250 250 250 250 250 250 250 250 250 250
250 250 250 250 250 250 250 250 250 250 250 250 250 250 250 250
333 408 500 500 833 778 180 333 333 500 564 250 333 250 278 500
500 500 500 500 500 500 500 500 500 278 278 564 564 564 444 921
722 667 667 722 611 556 722 722 333 389 722 611 889 722 722 556
722 667 556 611 722 722 944 722 722 611 333 278 333 469 500 333
444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500
500 333 389 278 500 500 722 500 500 444 480 200 480 541 250 722
722 667 611 722 722 722 444 444 444 444 444 444 444 444 444 444
444 278 278 278 278 500 500 500 500 500 500 500 500 500 500 500
400 500 500 500 350 453 500 760 760 980 333 333 250 889 722 250
564 250 250 500 500 250 250 250 250 250 276 310 250 667 500 444
333 564 250 500 250 250 500 500 1000 250 722 722 722 889 722 500
1000 444 444 333 333 564 250 500 722 167 500 333 333 556 556 500
250 333 444 1000 722 611 722 611 611 333 333 333 333 722 722 250
722 722 722 722 278 333 333 333 333 333 333 333 333 333 333 ]
/Encoding /MacRomanEncoding
/BaseFont /TimesNewRomanPS
/FontDescriptor 42 1 R
>>
endobj
42 1 obj
<<
/Type /FontDescriptor
/Ascent 694
/CapHeight 662
/Descent -213
/Flags 34
/FontBBox [ -167 -216 1009 878 ]
/FontName /TimesNewRomanPS
/ItalicAngle 0
/StemV 81
/XHeight 447
/StemH 81
/FontFile3 43 1 R
>>
endobj
43 1 obj
<< /Filter [ /ASCII85Decode /FlateDecode ] /Length 16425 /Subtype /Type1C >>
stream
8;VFf#uji))G\A.)C+_W_@+(?;#t5WJge`f\,\:%m%U/G?jI=5"d94D+BGjA&]V5c
BFq!iM\IlQ,!oiP>Xkj*N1e[Qj&.;u<2[e4K,[H6-BgoIEf*bYXT+O7V38i?,oNT/lAXC6
8i$0cHRbSPN)V;u]eW=$psLZk8%.8E\"[&]ICKmhDIKP
^RSZSIjBg]e-UT4So:09]u0]r\FJU.(dENJPmLA:m$Idi"QABtM^B>heqmX".acL4
1FD3WlE^f'BsV)YHcYoO?)ZS%//gGiL/VLd'LX]-SO85p58G;c!0YmrCO)OPn2t431HG?RJko"e+Xr5
DLMukcH_96e*6l[J%bmL\KQ#ek+8"<@c$s,*s7)s7V&s5;V!]9d&u\bZK?Bm2;C0goe-YCKeOWu>DGh"DVpk_>$h[<\"3mYi
cuuc0:"!pd2sjBGdYm?D3gNO6(%atA'>9+FVg$T9oO7SE>tNYrkNGR7L_L`tJCS<.
U+"1pXFQ51J;%!3OUqT1@Nhc\VUrVGDt(?.qNR571mPcZ*@XA)$#Ipr'ZK::.k@[$
%@%ik_4]1T)QKX.2N'@J0ZJ"FmX'q)?kn2pS/L7)E%^IVa/cNse`pt'-ESii3-$@M
IB_SeO-ChbRN]Jj2H`p;mCD6Jr+7YRJEA4',O]ird>Vo:FV)?8BpO`M2N2>^rL]%D
!c7W]'Yp3?pjmqJ/0;bdAk")@]\6dhXke19R6
.mLPomLu>`]]CN*>>)1Y`
&.B9a4a;lLeQ/Ah+>;jnQ.3nLJbqC8N-+j2B[Ho3M.A$YS5g&L'k;hFZoL
?$:A(@+PdCUNA6o%gRp(fD>:<[J1.=[(L_aI-iG&.JDNQ:#]s-LpJ7=0B+O@-j7ik
`\2j`95;R:?2oi_,BPpgnTt1jk/.g<'45:4j`X)l%GmK1dsAWEhqWG`r`??_Ctl04
*5tLAWO1t:b7g?u.]&,1optb]eh,EZT=HC*TqlM@.?dpW]d>]r8\2?Oh>Pk#f(Zn,
H2/3S.(h"]Hf6a+=:eff@i8tkq2H;2iK-T!&B+U,kS5b=a2;s^[\Ehr]3j.>+L`_%L]SG(Z79I1HU@Z-
)QXh;*(O`u":Ycj*9(pno)LcX)B^d=i'p_?-mZ]m9Zud?'Jn'p(3am#,A[7]F$?mA
3INc.lHccJ#ObNc#r?%;@&mj#'=gGbKV_?3/5pG37s/ah,pHZdUr53WAt2%jHKld'
TPeSb1G;`5G"BbMA]J[5@D:a.e9i0fq7#m(fk"As1kD&$6u,M,"+E$*PYRR;Z&)<.
,fSdY$(B]fad2;KXJI$j2=%%^:r"Y=)p6AE.(^uf_f"+D7LW.eh<8n`I*NOjH,+!D
T:+/gjPkq0pH"o*/\6sEPub*:PT+Coj'R7`8Fg>3IR.LL>\l#k;[Di#RpeP%$qJ8-
@=O>Ge-(\X%p0gUc258J#(7V83%g+p">q0t@JZYXUR`LdGj"jr]^"JGea3,UfKR6)
'';3!+lQC"J-nP$F`7nFn"9XfORSg-<5Smj@C0GD1+JA[i3YUC49D8q-M9u"7AaKp
VHY#:3&&W5-pEa94*\.!5e3]QTKZ=9iZ_K,nCd_++rcD6Jq0TL5,mX1N^-S9d.5FK
2E^2+rRtTpm^T9/^_1h43tF
="Qi6^dPEl:V7HF/]HROW4UjIQ-Z62
HPUg06C8:rV%:bR-t/1hf+PBHO04NpkH07j!phHFl4[PC&G/;>k')_\/g#,l0s?tD
ms"e@Zq>kK\?[ODe(ofq8a'lRhpu]d(F6:TNM&!0D@BP"3Eqn;:hhS&[=
jkN@@mhp`VWe*4rh@hT273;1XYS]?8I+Mf+X+Rc1iTqI;X"T"=d>rJeML#aiinYDk9AT8_C7Xn[(UTU@D9S.I0^dp/.qU)Y>
5!JKK5uIk[GQAJo0$AL%5!a/eI&=U%B/'.NPF9BmQ)Z'!X,^/9IHAO'OA,DgP+I#T
eRY!*B56RLI/cG]e#Lq6>SgfPMn]$/joPof\g`T^%H`W&Q.nsd+gQMr45U@9cmA1B
h>Nm,jsU=,i(07/bEH]pI^HlLEaH_/2J_b>Ft275h80cmcWFn\Rb?uXiiTe5:@N.g
?[#Rsq4dS1>A^UfU>R`o2(JUqC*s$UXD3,a.@5C9Y&FY[^!g0AEosmSFL)Ctp$f9B
n3e(/lVTKU((RUR)/LH34Q('hYee)Lfj#MN,:p$#JAJeFKdF,>:'e8CaZ*RZ$ZJUl
hWUjD'"%W[=sLD1?pEb`8$kVgJ->n#>q,;6oEqAFQ5D2`
a;I)]=2R7;UXdTGq!37g")a:Of+oq@4X%(b"f+sl!.@0j7g`,2e8]eQn0R_'dscJn
>QZ<1K=f36+c$i`E;Dnk4uiFl$uutAKJ2R.BUAd[Ggi&.QVL8e-udU6@TI^G//Yl3
F?ea]+;4#DY_Qd+^d;0;%34*\(dEe:_Xm`,M[gI9W_+KC/!["bakGM"c7USo)iYhW
L6Bm:LC7FHKsY643NUV_2A;9@n1-CYdf>\XiT$CVq66]cJ'b!4,,)ljj1
/KRA7N5RAg(V$2$mWu![ciK5o%M9K/68kKPi!RU((reC=kheYr$,H+O[>oL5s@7
7(Z/bq#t@,X7hiMr4/[Qn.fm\"_]bX,[O^Nh(PH#Z0"SZ#ea.RVTTOD-*uV?o5t"/
&:[La>'hSDmSI#EEkOL[TV(`aaPQ_et(QoAp
=fjf6i+Pm"WhtQ&1p);u/9"G$R)7Bq=eg])@o.PH,F\__$X`in(QA,]?moI/:01Xu
%G`#&O28HQO-X$WO=0GSpo8+b)k/mQ4\h'b6\Wc'[PqJT>N4sp*sam'AJo(=j/;2i
"ioBW,iA+Ifb)Y9UTBWaoMUg4GQs$Z*&2Ti\lll8135fs#$t$(,JR4s
\iE(Y)k49)*?unLc-B"FMEV@%mj1j=)MbZG)a.Rc:8.1poA*t3C6=\MR$f"e4qg?L
=7[B\iDEDN"6T*uo``DVPn()%51F7;QZ`o^Tbh6's,ZAI37q!dB+7L@"?s;1OW*DX
6&(qd\O3Uj8i(#T`8kjLLX;k+U,e"fP@8Nqdm5^b#[8b:]
GP!EAb47b-;lYBuRBoXAIOKb#(i\A[Q/K0A.bUV+*Hu?o==g14^[%%4Ti6]G9!eNd
LqOre:NWIq+gg\gqH>3*TiXS.Ki85+]JWO(BbOl*%F0:,4YTI0Z
^#&to#iNig9J>h1g8j'=aV.k)F80*O2>e`2Ei.7VB#.@[,H:Sp;Bbt7E79]?8f^8p
Ggd>_c\5*Xb;ZBtpN^PN,FJ
'AoG'>+L4fJ7RenOTJi9$/e0h5p(V=\0E$ALH[hLJF8ZMkm0J9ed1[AkRL7i4A?'-
YWkk6/^`"-%ee=Y$'nXZ6d;Y5%&D*fTB>?;+f2brHaO,SAMC^cl+AXUPHa6cS,>9s
Hlkp6at>6f-ka9Zk;$]?g*LVK+dq#GrFVh.%#^!cMVh.[bsth9ho_O7gS`dCXQlF.
$LF",!\sQQNWL.q'cN56peP]^q6uJsEpIqr:
S1LB&s#@4UTVg!c:(0'_!N<-=]W_O.T/PHMh%RQncjB-#8*)2
70j6p;?R&S!$NL?i>"e=<^kM8*j/;ikb9kKFgjP,m@KgGE8<1Ue':oRmI![I\2-/&
3PY#FIc'V090$0(r0(KX0,B"fLp$jR4cCB&Pe=R0AMjq(\h5Y>RE9A#Okp[OqP]@bemP5d#d'GIaf[pHJNaPO$O$!k4Ye*ER:$T!3SuG78L@1ogkp
"*"lp$>>eRJfaJqSW&HJ:DJ@Qg`d)_p.>"Rf<3X6LmdViKf@_>:br-5*0OLg.^:DS
^h)[/9qc.b4%*t=gt3n=17.2sZ*@J-hV<<3^*s$ha3W(4nj(?H;1Dd"Hg)*=RKtq,
ZG/1CNPBo1nFM.AE30M`SLWVB55^&SD9hKa&U(Q%m(sf.Q]hMOgOe^Y
AoBL4QPJ9%/4Jp+b&+-o)HmUiYt^@N]Qc8]SVhuSnKFV:moc^shGN4KE=\e0#92>;
i_/C5`E.[or\J(5GNCiBO`9>NFEI(>O1:B%5
^nuJ"#EI%5#?XZIfm.>j(3Yrp-en:j&gZ_@HSZOuNEHO.LtjI_;k6a'51GC.oukIt
`TB%UDs
\n[q]djm"jML\)F4pL^]%iImZY2[-gk"gGCYM110-0N.T+o7D`1"LbRsefKY6
SZu-`:*\%L]GPte\->;_bL0Q57)L8%A`:K6p((,D)SRSYI_QSTc`(ugTZJnLI!]@M
)tSoD"Su@h%8iM)[kNT_Ot)2'p4e6JqaP;nl/EC[*5+,c0(?^E^>:h[>dN8kq_#g$
@>^1W(kS])\?$Y5.'Qosl[:V1%rY#REdHXFS/56s^T%lSamCI9MSpEqZPi,%1F65i
6>9MN5Q)DS-@a#^W)tDl`#:Wi"!c^K\l(d3&S^3p;2bp@L5Xj5d^AajF_=b=_U3Hi
=2\UW]>m*'HI>`S\.h`d!@@!(BXKOAPgg3cgtj;nQ,-?s,kFN[$88RMEELGCqOCln1c#&)E7/
E"1#b*JS,9rcLdX\/KU5>8s#9,!rFYP&ds,5Ha)
+tPi5(ca-PXmNLoX)HK;)ao(D*l19LBe:*&BAp-HZ!b),Gh[:L<2+l(#jtGi2_n37
YdG;q-UgUE/J4?D$_`M9kRH6`>2,H,O$Pka[buMk;!V]NqUG&We&<+##d.Y^-Ydb1
s6[]*[mb*T*og4bUq'X)C2T?9;H"m)<"\!q-+-qtItQKq:XUUNH]KR]H7"4Zn!6OS
qQ_tc>Pc0g_;;;S'7.]\?'V(eAVUZlK2d,FH#C&E6`.r@k]SGtLePc97f4m?I/,YI
e_O&=HV-WcA6"&?Cl^uUS&_1iBJNH/DO;!`"GsL^ai8d>38hAT@"O5qZ-2$(dT4AI
[NANX97M;;i7M5A&)ID'$Xg-
a&Be(U3Z1-G!!;ZDA'HBJ=.3J?f3r*=2J,m48#&%O$\1D?j%g)Jneq;o_M[HW//K4c-dA!=hiZ!XlJXR)jQM(4[^ao
0B;.8e5UV3E@B[jh5YIagU*MuD/No*99l[GKi>ouI!XULn
+s;Ph"ADA-MhDXOOGAW/@>g#c>&1*;=k3hfXA,C4RchaEGS;EO[G:sAU!',,%=I4R2Weaai#jMAL^9^
PYQ),0['OK9-:uI::$`Fq#3DN/c#^78.E&$?ETtrEI`XU6
:/%\[@e3+JmA5mdo\edP^t\2pR*T10%\p&0&OE_1;5C9.X/c;P]'Qa$[>SakUXDk-=F`1Nh
)(d9XaEZeE#`)-3ZXRto&B\lI&X>[gO2^5F1b^^]Y!lap8nW#Z,qE].6q9mX,1aYaF&]X5P0eTGG!SYiJO/_qgd!SSih+DDtf
*e1WaYO%(%X()mJ\$Z>qRX!mY8MjIQ/PF<^akVbG;a+J2
?5*(PdKr[n68s.-H^GYG`f>@OSLYZsLZu=`p]I<(_it]^rduD^&Y5.2+M%;qm4V
#4c?+?"^WD&*'P]=S^4["7,UO6cu:7f/j$p];F1ObtLgde03Z1`Z=N$;^,MHXu)db
Bgj3q-93_F`TP%=0Lb]]d'DS*LI/dkoXn`5.s)'sTDZK[.(r8@j`^R_j4't/1!'WOg3mEf)CemC#>"?1<`:DcV$al
`tNN8-P?'au:Q$Flc@)F[V3[pX0ZgZN\n!i#g5
i0.TWo4Zcn\%CI*HVoo->Z>5M]+G@a#3q\VgPGrHH,[[$;e&c,UcUXV2=5dhPc(_?
IciR\O/I>'%EpBu!#+;*Jali`D;E=ooJ0ZipUiGI`U&4;Ql!L>'!WpU':#t:fN,Fh
bE/<&dY6N_Nm_5*eF!O_A&.-e]%m&CA+'Hp*dP:#r#P^'2[6f\rKu;_Q+E[(5Bk[V
T%D34D!nBDcop2co3g/BT0mKY%"_SiMm0aZfoh)RrgN#[0"U.@Y+e3Z6_13`tRCnGfBfG6g(EUkm@Rt')Kbd<^jGFT7Ur*[0$=gW@T=RdC$'`;%
=N;)Tj]VDd[*E-(=ptmN=++?j\sj!,L4Qti'-Z9?C>gr;V6mE=YYgq>A-TBS07A@?
/Stutd-&5*So#)B#CLJ$Ic3p.]]k%lph;[1gX@nH4*4!eTKDF:8X-X2qJ&K_JAFs)
kmVa0]uJVuoa^9hAZS^'>V[!7[P69Clph,m_9[mFE0gPmj/uJmmNpk^KG"-&TJI5n
9s1P@&A*O<&;D5/Tbo7'DK`i(Pd]MIC[A&s6GRYc5HbY/^E(9s,l,k\_;-kt_YL9j6m@@E*
AZ4fjL_WfZ^:V$"I/>ZiHKO/[K,#H3`q3a%;nUqE;Fp5$2;?$^kHDGn^)t"1-dLW-
-_HJZ&BJbLOUDD7;raV1G0lBP^I)S0B;6jFO4##]P;0LiRji-473o""anB(;]0:`;
`r%.A\H4FV]Q)K^s5Z)j%CMth]@=esh\^)]S@t1V9SH*4TVSGWe6?$+\)P]R7NRB?
Nq8B5i?&Jg'TlB9A6$A9IT7DaXl8-TOnVu2Km3IG%bFr<^i#?\Q4Q7s<
bq1Qn7;gfn)6gY?rZL"8/+AOb:XTp:B$UH5)s)*/c!m7FoCrGG;*J;?^n7/4\tYoQ
c`n_W'KZ%\H%CL&RM?0BUTjY9H"m\O@fF_!i($5HKP5FU`NB=+R``.XIj$U=bMUrp
kZV0+3lb
J)HYmg6okXZi*#h/r<s7LR>q'eUYqYm+ZYF0cl9gt8^
)H[$&@;[('K*mDCj+&BSVS$)_RQ0muC"t8QnaIg,]k6#)ce=0Ak])Ip&b#@nKo.!L
OI,MPH%h@L$7$`:-jkW_+sJ?F^r1bSJ-5oW748\c#M.M+LY!D)d*pAR+A:f
g4'&S-UdrJ*F`-MF6jSrP--*f+(LsE4m.>b=@h:"/Qk"[=m($VaaFn1KL@(0Jo$)"Pq,HL1NU@X;_$
:1H!!1f?4_/1-#kl009%S^'(3`FUAA1;5mp^7p^nN\FWdbE>D<=aINSVk]kJ'UBgU
,I+_Np#TjCo#Am:0EXWu>`&_PYeS&$51FP*<,o*e\5UnIEDe"&84e[sq\AR/65!J>
BkaG2-EC)/=c9PmT.Z#XS">jQDi1Le#nR:$q8>`Vbo&D'jjEdC#aat:nr"80Bi>EE
mE+M9W8Z02VV`5/U%NPCSM!hmA]#2@6g4*dRYGFVI;F,akb)UnHIUHh,\d!2'Qr-U
+mcE9R_b#.*UNR*&=Ve#]LV`M=s*$TTJ/M_n[Z-2$`H^E<$X_%2RoO6&cJmE=Nit.
1g(napursad"S\CMKo;#bTFV@@_SE1OT38;d*T^as,ak)^V;j_@JPs\l'C<'&=2eM
(&A3D+@%i<^SW$^E(e]ME%X+F/DlZHR!,L8;PgC(<0\2u$G*Ys1G:.3AToWi0P*%j
9AL'o+#`Z^X;ufL5reI.G(a%`PP.UtEJpea$99[9[Hds#g1NCS3DD6KNZC.V9;`LX
F8EY70C:KJ;"i=`a6%55B$OFbI3St%)s2\lA3@O@8\m8sY,K7firAnVc)qOGD*Q(,
]ARqCcZZYIDSf(/fSBjLb##"dX8AEaVu%N_o1eG$Q#*FY)H.f.<(&1pDr#jJpu_!R
i*U)MUNUSuNP:"]?ln+R]n6/[4/$s"aO;6E08aX6,WNUZI=K#YU9NuU;p*RWjQ?)Z;4(]km)D3?-5]hbo5;H\OjGKM
ig_ljb&tT+h?Z+48$(Y`]Rr*RC-`DI+J,\8M3l!mY6E0'_)nu=etjV(;deP$Dll+#
Q"UVH63%LV_-n41=:&bZg24'-qj:l9D)PYEY-m5LNbcO:d$Ih%>A7r<6D7m(3eO/\
ri55JKjlrE+>):`'i/JSFLV'l%!lRHYEC>A,5I=(nOD&')cKOt?tLX71F[=&oNFc.i^#[8f^cWR3W%KT3^
lG7?XPOS1-=D!Sg_Th!lF!b$>VeUq]Xh:.349$Z%L^NL+*#Ro))An:s$4MlP$tNNX
)teNP;(kX7OP2>#dFN+4MQ*HXB'c_gUeW#s:r\=0$0dVdHRm6[RA*C75^iSs/Nn't
3+b`A)>lTp^!P!\3'ta8EhX17gIID3qK0as
btNR<;4&dcP10CRmDF).[8eSjB)A0R17%7$VK(se!p$Qo3BY:ldl=YCLh:Yna"mXT
qe\=dF.!KX$mh>n'1bhEds#j%11b/>\J6one6j3@Xahl.;<6GoPSHk-=$V3@Y!f,e
1\Oh"M,C9Bc[\YX:ndrdJ8<"YWN=?(=UT>rQM:OP_2(.'Hnj$W$IK?!dW!:Qk@X$Q`R\-EQ
VUK7"9p9/4d!:RmJA_/4]".;"i(D3!gEE#$TYmKB?oW,ho3KU.Cf299?-ORZR"PM&FIL@VNR'uBH)=9C1"cGf0a@>&B?
'6oaojO?=\0pV,7L7P![#9-aM";:c]/0YC&F4[k(\b'+
,o5Z/@B7l\4\mk!g1o@JoZodq7]=Pk9ND/tjKIR!7KhCI.M[[V93u=IOt)niq`dC:
BHd3djrnC,X05I$l<12oWi]?:Bm;1RRQ=79B&3'c\bBRa\-Z1YD[P6AY42>kEnUt,
i-4\f2V8H(Y;\p>1(HCV787a*M,uJ6+&)1_/8(XDI=BjlQ1%adf.io>4'-=tNH#b5
]5i)_nE=NfkUjos;HZ`jWKs<=I@[K_`g\:2_/(kU9Zf`kH4\gViYZ$b
=Q;/"A8)spbQO;-WF+'1O8`XhJQ5_a?7?IpT?t=?m3#pE8RY\l0Ckgb,dGIrFDt.@
(LL?@KA[,\95-Z/:1aVSe6$GVn5]<_UV@W2i.`]KFuf"G-I^_Z8Bbo_m=/5(PTR"V
YGR@r9AJ^ka>PoVb;6P/9)PDe%dCWoLa&a7&H?1Pg7t)rZhVP%R9DFn(^=g=Ch@g<
e-AV3K2_*=70MlpOJa4/K+_'*@Pe35\njfD7l[YT'l,!(GsiReNE&eC/"j.:"Ee!C
ZTR6ZZHB07hSG8EZem%Lfr^jPrip,8\9I@bn!uPtmsb#f%jemV!D5r(%EV1^ej>3m
Drs3jVp-:F#>k2GWe3n$9lI#SD5`_NkN1EP$YECdZ2EPCoV".Sj-!u)=VH1X;U"f;
3W'UudM0HqGjthA+)AQjhBjS[]Io<;[G"[ur;m6.cJIes$KV)A(
Dq:I\=lf?GkfkP@J5X03X\/B`k*t-CD`esA;@A>?uW101kFcM64frTT79"cEa?0i3dI3j\u@SnsUVk5#!;l?p#
%J!Vl'KJG]IWsk;)Fm\).u+ru)CJq1Y4Cm1N3tca"Y7hTBac[l$%'l;G5GG>7Jdub
[2%hKnUDg&E'HO"0+D%rTNsCP:l[?l*5%JBKtO>,ijR*;[T1)O8A9T"T)Gt#m&r6[
>I-4WT2F2BSm0=nqeJ9AMWG!e[Iq.0;dHHjg$bE.+j'9t1dsSNHNag,%>-_HE8\if
PZ;Pc+%bqO@l+_o)5C?EI5-W]agHD!*(FnUJW.e4:9`*<,GhnB0bt@.?kFL>")%k1
M*A;^.aiU/LqaLHR@fT"d:.m-p7'$#@gg#P%?)Kn1c6IDQ@;YIW\d[SaQkcBFit,J
NJC1!B#`D(J*$mGWmI-[`*>IVe@^^93jjW!5::.IUZ.`b=Kp*tWCCur<,G0*,qso*
SOOC;8SPpVM@K()K\HjX[R6&]DV-CbC&\l.B/6&FY4"Ts?"/he1*W19K]9b&0p&)6
)7D+QP*\pa_>Dp'7*\"BYga&?,H->jZA$aqZRCYMe=ZM.Io?@SP>Ss=4t"6b8HHt]
c".O@aHa0S.D#WZL.#@H>,]0\mT3HlLP3s..m-$)(Z==uaKX-,ojB3R.gath?1jrH
S&.KLK]Dq;s(ebY%b@Za>WjdDI%lm@G[#"[640uf!PE4+F:F2FF,o<9`.=BpD\,>Jm`oeSl,+P/
@S8aRR/>\a7nhPD@4m(+f)%2OVUbt6t]:]l7"GMkE"&^$Z0tJ
"tomgcLjt[3j5si?(U6pZ8uarZIj5"/iB/9\U6#QKj9L5%'[gk]=3DV6ZgK]S%HWn
rQW=Zk9)N*F*i^>_7(<'OBn8@"eSPer-a:X[9Y=0)':a^ERIrcG5B2M=V7'hg"WYEL"=?qpWdQWU4=VtkZrV(__G
gfVN85H7Z%Y"hd:BD!OXji[DD/!Q[,;qR?,dZ)JZXR1=V;r6Kf4i\RcW?t%GMldIj
+k^'CdL#:IE0HS2(*ZKp"
0+M+6lni)qbs`FBf4L+`D35d1O)\
lqCPp_?rGPWX76f<+K)d"rh\8AFjY[9k*dqP*l1F0h1!q02i`VbsNPn%?9R>pujbc
/r3Wp.564dN-F1fB"N_2c)O$f^TpI/Xt[R[h9O*?eXFo:;r9t1_+!T$T]acH2PKkX
$*>8*f7S"&EtD`5d(K12,!/"dN;&I;<.hsT+TKSVjR;*YQkLObWJ)&fbkD'/1[:)Y
a84YS@upV%NqN?+a.,+R1%@rZ,6?h[G!<_fk0NUX[#WeI@n2QNaiuCcaCY+Dkk68X
8;=$^,Y+V:HiWRTX^>Esc0E$-7&rZ(+UjN_p>\B0S[f8K2k/e/%BP\BO(SEA+QZ$'
"b&@cFE'K&LiRK$2M`;UN=`TrOP:o7-!P&8BKXVX9Wf*Cn-oP'n8#p:S=E@oG2hS7
g9?cBWtA5=#Ca.d(8a:)YR[Nr\$1T[*\lmTHgKJZiJsV93ekN:(^d*qu*g=6Cr+5g"'Q8T@Wp16+XNE`C^rln*P
8A"G#)"uIU!\r9k;IU7bmG]gVEs\Be@]WI5W<L`#&a26,pZ)O)$d"i]*U\
endstream
endobj
44 1 obj
<<
/Type /Page
/Parent 100 0 R
/Resources 46 1 R
/Contents 45 1 R
/BleedBox [ 24 23 631 877 ]
/TrimBox [ 30 29 625 871 ]
/CropBox [ 29.76378 29.76378 625.23622 871.23622 ]
/MediaBox [ 0 0 655 901 ]
>>
endobj
45 1 obj
<< /Length 13206 >>
stream
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 101.8661 799 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Alle helseforetak)9.7(ene i unders¿k)9.7(elsen br)-19.9(uk)9.7(er datastyr)-19.9(te)]TJ
0 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ontroller i kv)24.8(alitetssikringen a)34.8(v)-0.1( k)9.7(odingen. F)49.7(o)0.1(r)-19.9(mŒlet er)]TJ
-0.4902 -1.2 TD
[(Œ identif)-59.9(isere pasientopphold hv)19.7(or det b¿r gjennomf¿res)]TJ
T*
[(en n)24.8(y)0( vurdering a)34.8(v)-0.1( k)9.7(odingen. Dette gj¿res o)24.8(g)0( e)24.8(v)14.8(entuelle)]TJ
T*
[(feil rettes opp, men unders¿k)9.7(elsen viser at erf)-9.9(aringene)]TJ
T*
[(fra k)9.7(ontrollene i liten g)-19.9(rad b)19.7(lir dokumenter)-19.9(t o)24.8(g)0( br)-19.9(ukt til)]TJ
T*
[(l¾ring. En del helseforetak har positi)24.8(v)14.8(e)0.1( erf)-9.9(aringer med)]TJ
T*
[(at o)24.8(gsŒ a)34.8(vdelingene kan gj¿re n)24.8(ytte a)34.8(v)0( datastyr)-19.9(te k)9.7(on-)]TJ
T*
[(troller i kv)24.8(alitetssikringen. Dette kan bidra til Œ utvikle)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ontroller som i st¿r)-29.9(re g)-19.9(rad b)19.7(lir tilpasset risik)9.7(obildet i)]TJ
-0.4902 -1.2 TD
[(den enk)9.7(elte a)34.8(vdeling. In)39.7(v)19.7(olv)14.8(ering a)34.8(v)0( flere personer i)]TJ
T*
[(utf¿relsen a)34.8(v)0( disse k)9.7(ontrollene vil o)24.8(gsŒ f¿re til at k)9.7(ode-)]TJ
T*
[(kv)24.8(aliteten i et helseforetak b)19.7(lir mindre sŒrbar v)14.8(ed perso-)]TJ
T*
0 Tw
[(nellutskiftninger)54.8(. )]TJ
ET
0 0 0 1 K
0 J 0 j 0.3 w 10 M []0 d
101.87 618.49 m
330.47 618.49 l
S
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 101.8661 607 Tm
0 1 0.65 0.34 k
/GS2 gs
-0.0001 Tc
0.0278 Tw
(9.2 Konsekvenser av svak kodekvalitet)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 101.8661 583 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Styrene o)24.8(g)0( ledelsen i henholdsvis de re)14.8(gionale helse-)]TJ
0 -1.2 TD
[(foretak)9.7(ene o)24.8(g)0( helseforetak)9.7(ene er ansv)24.8(arlig for Œ sikre at)]TJ
T*
[(re)14.8(gnskap o)24.8(g)0( infor)-19.9(masjon om resultater er pŒlitelig o)24.8(g)]TJ
T*
[(n¿yaktig. ISF-refusjonen utgj¿r en stor andel a)34.8(v)0( helse-)]TJ
T*
[(foretak)9.7(enes inntekter)54.8(. Unders¿k)9.7(elsen viser at sv)24.8(ak)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(alitet vil gi mangelfull styringsinfor)-19.9(masjon i hel-)]TJ
-0.4902 -1.2 TD
0 Tw
[(seforetak)9.7(ene. )]TJ
0 -2.4 TD
0.0249 Tw
[(De re)14.8(gionale helseforetak)9.7(ene br)-19.9(uk)9.7(er infor)-19.9(masjon fra)]TJ
0 -1.2 TD
(DRG-systemet nŒr ISF-refusjonen fordeles videre til)Tj
T*
[(helseforetak)9.7(ene. Resultatene fra jour)-19.9(nalre)24.8(visjonen viser)]TJ
T*
[(at den sv)24.8(ak)9.7(e k)9.7(odekv)24.8(aliteten kan pŒvirk)9.7(e ressursforde-)]TJ
T*
[(lingen mellom helseforetak)9.7(ene pŒ en utilsiktet mŒte.)]TJ
T*
[(Dette reduserer de re)14.8(gionale helseforetak)9.7(enes mulighet)]TJ
T*
[(til Œ i)24.8(v)24.8(areta sitt ansv)24.8(ar for pŒ en hensiktsmessig o)24.8(g)]TJ
T*
(rasjonell mŒte Œ samordne virksomheten i de helsefore-)Tj
T*
[(tak)9.7(ene de eier)54.8(. De fleste helseforetak)9.7(ene i unders¿k)9.7(elsen)]TJ
T*
[(har v)24.8(algt Œ fordele ISF-refusjonen helt eller delvis ned)]TJ
T*
[(pŒ de klinisk)9.7(e a)34.8(vdelingene. En sv)24.8(ak k)9.7(odekv)24.8(alitet kan)]TJ
T*
[(der)-19.9(med o)24.8(gsŒ pŒvirk)9.7(e ressursfordelingen mellom a)34.8(vde-)]TJ
T*
[(lingene inter)-19.9(nt i helseforetak)9.7(ene. Det kan stilles sp¿rs-)]TJ
T*
[(mŒl om k)9.7(odekv)24.8(aliteten i mange helseforetak er god nok)]TJ
T*
[(til at infor)-19.9(masjonen fra DRG-systemet b¿r an)39.7(v)14.8(endes)]TJ
T*
[(som g)-19.9(r)-19.6(unnlag for Œ f)-59.9(inansiere a)34.8(vdelingene.)]TJ
0 -2.4 TD
0 Tc
[(Alle a)34.9(vdelingsleder)-19.8(ne i unders¿k)9.8(elsen har budsjettan-)]TJ
0 -1.2 TD
-0.0001 Tc
[(sv)24.8(ar)39.7(, o)24.8(g)0( er derfor ansv)24.8(arlig for at bel¿psmessige rammer)]TJ
T*
[(ikk)9.7(e o)44.8(v)14.8(erskrides, o)24.8(g)0( at for)-19.9(utsatte inntekter k)9.7(ommer inn.)]TJ
T*
[(En sv)24.8(ak k)9.7(odekv)24.8(alitet f¿rer trolig til at a)34.8(vdelingens o)44.8(v)14.8(er-)]TJ
T*
[(sikt o)44.8(v)14.8(er inntektene ikk)9.7(e b)19.7(lir tilstrekk)9.7(elig pŒlitelig. Et)]TJ
T*
-0.025 Tc
0 Tw
(ev)Tj
0.9041 0 TD
-0.0001 Tc
0.025 Tw
[(entuelt a)34.8(vvik mellom antall planlagte o)24.8(g)0( produser)-19.9(te)]TJ
-0.9041 -1.2 TD
[(DRG-poeng kan derfor sk)14.8(yldes sv)24.8(ak k)9.7(odekv)24.8(alitet, o)24.8(g)]TJ
T*
[(trenger n¿dv)14.8(endigvis ikk)9.7(e Œ v¾re et reelt a)34.8(vvik. En sv)24.8(ak)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(alitet kan gj¿re det v)24.8(ansk)9.7(elig for foretaksledelsen)]TJ
-0.4902 -1.2 TD
[(Œ vite i hvilk)9.7(en g)-19.9(rad det er beho)44.8(v for Œ i)24.8(v)14.8(erksette tiltak i)]TJ
T*
[(den ¿k)9.7(onomisk)9.7(e oppf¿lgingen a)34.8(v)0( a)34.8(vdelingene.)]TJ
0 -2.4 TD
[(De fleste helseforetak)9.7(ene br)-19.9(uk)9.7(er indikatorene antall)]TJ
0 -1.2 TD
[(DRG-poeng o)24.8(g)0( DRG-indeks i den l¿pende styringen pŒ)]TJ
T*
[(ulik)9.7(e ni)24.8(vŒ i helseforetak)9.7(ene. I inter)-19.9(vjuunders¿k)9.7(elsen)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ommer det fram at mange mener at DRG-poeng o)24.8(g)]TJ
-0.4902 -1.2 TD
[(DRG-indeks gir et forholdsvis godt bilde a)34.8(v)0( henholdsvis)]TJ
25.1283 70.8 TD
[(akti)24.8(vitetsni)24.8(vŒ o)24.8(g)0( pasienttyngde i a)34.8(vdelingen. Infor)-19.9(ma-)]TJ
0 -1.2 TD
[(sjonen br)-19.9(uk)9.7(es bŒde til Œ sammenligne a)34.8(vdelinger med)]TJ
T*
[(se)14.8(g selv o)44.8(v)14.8(er tid o)24.8(g)0( til Œ sammenligne a)34.8(vdelinger med)]TJ
T*
[(hv)14.8(erandre. En rekk)9.7(e beslutninger som pŒvirk)9.7(er driften i)]TJ
T*
[(helseforetak)9.7(ene, tas pŒ bakg)-19.9(r)-19.6(unn a)34.8(v)0( infor)-19.9(masjonen fra)]TJ
T*
[(DRG-systemet. Dersom det etab)19.7(leres systemer o)24.8(g)0( r)-19.9(uti-)]TJ
T*
[(ner som sikrer en god kv)24.8(alitet pŒ den medisinsk)9.7(e)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odingen, kan helseforetak)9.7(ene oppnŒ en mer forsv)24.8(arlig)]TJ
-0.4902 -1.2 TD
[(¿k)9.7(onomistyring, inkluder)-19.9(t bedre k)9.7(ostnadsk)9.7(ontroll o)24.8(g)]TJ
T*
[(mer ef)24.8(fekti)24.8(v ressursutn)24.8(yttelse. )]TJ
0 -2.4 TD
[(Innf¿ringen a)34.8(v)0( ISF har f¿r)-19.9(t til en bedre pasientstatistikk)]TJ
0 -1.2 TD
[(gjennom mer fullstendig k)9.7(oding a)34.8(v)0( diagnoser o)24.8(g)0( prose-)]TJ
T*
[(dyrer i helsefor)-19.9(tetak)9.7(ene. Lik)9.7(e)25(v)14.8(el er det for)-19.9(tsatt et bety-)]TJ
T*
[(delig omf)-9.9(ang a)34.8(v)-0.1( k)9.7(oder som ikk)9.7(e er i samsv)24.8(ar med de)]TJ
T*
[(medisinsk)9.7(e f)-9.9(agk)9.7(ode)24.8(v)14.8(erk)9.7(ene for diagnoser \(ICD-10\) o)24.8(g)]TJ
T*
[(prosedyrer \(NCSP\). Unders¿k)9.7(elsen viser at 38 prosent)]TJ
T*
-0.0351 Tc
0 Tw
(av)Tj
0.9089 0 TD
( )Tj
0.2749 0 TD
-0.0001 Tc
0.025 Tw
[(de unders¿kte pasientoppholdene b)19.7(le k)9.7(odet med en)]TJ
-1.1838 -1.2 TD
[(ho)44.8(v)14.8(eddiagnose som ikk)9.7(e v)24.8(ar i samsv)24.8(ar med re)14.8(gelv)14.8(erk)9.7(et.)]TJ
T*
0 Tc
0 Tw
(V)Tj
0.6111 0 TD
-0.0001 Tc
0.025 Tw
[(alg a)34.8(v)-0.1( k)9.7(ode for ho)44.8(v)14.8(eddiagnose er sv¾r)-19.9(t sentralt for)]TJ
-0.6111 -1.2 TD
[(DRG-g)-19.9(r)-19.6(upperingen. F)49.7(or 77 prosent a)34.8(v)0( de unders¿kte)]TJ
T*
[(pasientoppholdene som b)19.7(le g)-19.9(r)-19.6(upper)-19.9(t i n)24.8(y)-0.1( DRG, b)19.7(l)0.2(e)]TJ
T*
[(ho)44.8(v)14.8(eddiagnosen endret. En sv)24.8(ak k)9.7(odekv)24.8(alitet bidrar til Œ)]TJ
T*
[(redusere tilliten til at pasientstatistikk)9.7(en kan ben)24.8(yttes)]TJ
T*
[(som g)-19.9(r)-19.6(unnlag for planle)14.8(gging, styring o)24.8(g)0( e)24.8(v)24.8(aluering a)34.8(v)]TJ
T*
[(helsetjenestene lokalt o)24.8(g)0( nasjonalt. )49.7(V)39.8(idere be)14.8(g)-19.9(renses)]TJ
T*
[(muligheten til Œ an)39.7(v)14.8(ende pasientstatistikk)9.7(en til medi-)]TJ
T*
(sinsk forskning.)Tj
ET
0 0 0 1 K
0 J 0 j 0.3 w 10 M []0 d
353.15 450.49 m
581.76 450.49 l
S
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 353.1496 439 Tm
0 1 0.65 0.34 k
/GS2 gs
-0.0001 Tc
0.0277 Tw
[(9.3)-278.1(Tilgjengelighet til spesialisthelsetjenester )]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 353.1496 415 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Da ISF b)19.7(le innf¿r)-19.9(t i 1997, v)24.8(ar det et mŒl Œ ¿k)9.7(e behand-)]TJ
0 -1.2 TD
[(lingsakti)24.8(viteten o)24.8(g)0( der)-19.9(med bidra til Œ redusere v)14.8(entetid)]TJ
T*
[(til behandling. ISF skal ikk)9.7(e v¾re styrende for de priori-)]TJ
T*
[(teringene som gj¿res med hensyn til hvilk)9.7(e pasienter)]TJ
T*
[(som skal tilb)24.8(ys behandling. Unders¿k)9.7(elsen viser at det)]TJ
T*
[(har v¾r)-19.9(t en sterk v)14.8(ekst i antall elekti)24.8(v)14.8(e)0( \(planlagte\) syk)9.7(e-)]TJ
T*
0 Tc
[(husopphold i perioden fra 2001 til 2004. Dagopphold o)24.9(g)]TJ
T*
-0.0001 Tc
[(ettd¿gnsopphold har hatt den sterk)9.7(este akti)24.8(vitetsv)14.8(eksten)]TJ
T*
[(med henholdsvis 47 o)24.8(g)0( 39 prosent. Dette betyr at en stor)]TJ
T*
[(del a)34.8(v)0( akti)24.8(vitetsv)14.8(eksten har k)9.7(ommet relati)24.8(vt mindre res-)]TJ
T*
[(surskre)24.8(v)14.8(ende pasientg)-19.9(r)-19.6(upper til gode. P)14.8(asientenes ligge-)]TJ
T*
[(tid gir en indikasjon pŒ alv)19.7(orlighetsg)-19.9(raden a)34.8(v)-0.1( oppholdet.)]TJ
T*
[(En forklaring til den sterk)9.7(e v)14.8(e)0(ksten i dagopphold o)24.8(g)0( ett-)]TJ
T*
[(d¿gnsopphold er imidler)-19.9(tid at den teknolo)24.8(gisk)9.7(e utvik-)]TJ
T*
[(lingen gj¿r det mulig Œ behandle mange pasientg)-19.9(r)-19.6(upper)]TJ
T*
[(med f¾r)-29.9(re ligged¿gn v)14.8(ed syk)9.7(ehusene. Den sterk)9.7(e v)14.8(e)0(k-)]TJ
T*
[(sten i dagopphold o)24.8(g)0( ettd¿gnsopphold er derfor ikk)9.7(e)]TJ
T*
[(n¿dv)14.8(endigvis i strid med prioriteringsforskriften.)]TJ
T*
[(Unders¿k)9.7(elsen viser o)24.8(gsŒ at v)14.8(eksten i k)9.7(o)0.1(r)-19.9(ttidsopphold)]TJ
T*
[(ikk)9.7(e har f¿r)-19.9(t til at det samlet sett behandles f¾r)-29.9(re pasi-)]TJ
T*
[(enter med leng)-19.9(re liggetid. Unders¿k)9.7(elsen gir heller)]TJ
T*
[(ingen indikasjoner pŒ at pasienter med beho)44.8(v for lang)]TJ
T*
[(liggetid v)14.8(ed syk)9.7(ehusene har fŒtt dŒrligere tilgjengelighet)]TJ
T*
[(til spesialisthelsetjenester)54.8(.)]TJ
0 -2.4 TD
[(Det k)9.7(ommer fram gjennom inter)-19.9(vjuunders¿k)9.7(elsen at)]TJ
0 -1.2 TD
[(flere ledere mener at prioritering a)34.8(v)0( l¿nnsomme pasient-)]TJ
T*
0.0198 Tc
0 Tw
(gr)Tj
0.8723 0 TD
-0.0001 Tc
0.025 Tw
[(upper ikk)9.7(e er i strid med prioriteringsforskriften sŒ)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
7.5 0 0 7.5 101.8661 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0002 Tc
0 Tw
(50)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F1 1 Tf
7.5 0 0 7.5 443.4746 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0277 Tw
[(Dokument nr)91.7(. 3:7 \(2005Ð2006\) Rapport)]TJ
ET
Q
0 0 0 0 k
/GS2 gs
31 900.99 234 -10.99 re
f
BT
/F2 1 Tf
8 0 0 8 33 892 Tm
/Cs8 cs 1 scn
0.0099 Tc
0.0988 Tw
[(0272_RR_dok_3,7_innm 31.03.06 16:36 Side 50)]TJ
ET
1 G
0 J 0 j 0.5 w 10 M []0 d
1 i
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
/Cs8 CS 1 SCN
0.25 w
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
1 G
0.5 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
/Cs8 CS 1 SCN
0.25 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
endstream
endobj
46 1 obj
<<
/ProcSet [ /PDF /Text ]
/Font << /F1 8 0 R /F2 9 0 R /F3 41 1 R /F5 38 1 R >>
/ExtGState << /GS2 37 1 R >>
/ColorSpace << /Cs8 31 1 R >>
>>
endobj
47 1 obj
<<
/Type /Page
/Parent 100 0 R
/Resources 49 1 R
/Contents 48 1 R
/BleedBox [ 24 23 631 877 ]
/TrimBox [ 30 29 625 871 ]
/CropBox [ 29.76378 29.76378 625.23622 871.23622 ]
/MediaBox [ 0 0 655 901 ]
>>
endobj
48 1 obj
<< /Length 14256 >>
stream
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 73.7953 799 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Unders¿k)9.7(elsen viser at flere helseforetak mangler ret-)]TJ
0 -1.2 TD
[(ningslinjer for hv)19.7(ordan endringer a)34.8(v)-0.1( k)9.7(oder skal skje. I)]TJ
T*
[(flere a)34.8(v)0( helseforetak)9.7(ene b)19.7(le k)9.7(oder endret som f¿lge a)34.8(v)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ontroll uten at epikriseansv)24.8(arlig le)14.8(ge b)19.7(le rŒdf¿r)-19.9(t. Det)]TJ
-0.4902 -1.2 TD
[(b¿r i det enk)9.7(elte helseforetak foreligge r)-19.9(utiner som sik-)]TJ
T*
[(rer klare ansv)24.8(ars- o)24.8(g)0( m)39.7(yndighetsforhold v)14.8(edr¿rende)]TJ
T*
[(endring a)34.8(v)-0.1( k)9.7(oder i det pasientadministrati)24.8(v)14.8(e)0( systemet)]TJ
T*
[(\(P)119.8(AS\). Endringer i P)119.8(AS b¿r videre lo)24.8(gges slik at det er)]TJ
T*
[(mulig Œ a)34.8(vdekk)9.7(e u¿nsk)9.7(ede hendelser i re)14.8(gistreringen a)34.8(v)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odene. Jour)-19.9(nalre)24.8(visjonen viser i en del tilfeller at)]TJ
-0.4902 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odene kun er rettet opp i P)119.8(AS o)24.8(g)-0.1( ikk)9.7(e i pasientjour)-19.9(na-)]TJ
-0.4902 -1.2 TD
[(len. Statens helsetilsyn har framhe)24.8(v)14.8(et at det er en svikt i)]TJ
T*
[(helseforetak)9.7(ets jour)-19.9(nal- o)24.8(g)0( infor)-19.9(masjonssystem nŒr de)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(oder som er re)14.8(gistrer)-19.9(t i pasientens jour)-19.9(nal, ikk)9.7(e er i)]TJ
-0.4902 -1.2 TD
-0.0449 Tc
0 Tw
(ov)Tj
0.9402 0 TD
-0.0001 Tc
0.0249 Tw
[(erensstemmelse med de k)9.7(odene som er re)14.8(gistrer)-19.9(t i)]TJ
-0.9402 -1.2 TD
0 Tc
0 Tw
(P)Tj
0.436 0 TD
-0.0001 Tc
(AS.)Tj
-0.436 -2.4 TD
0.025 Tw
[(Unders¿k)9.7(elsen viser at enk)9.7(elte helseforetak har utviklet)]TJ
0 -1.2 TD
[(et system som dokumenterer be)14.8(g)-19.9(r)-19.6(unnelser for endringer)]TJ
T*
-0.0351 Tc
0 Tw
(av)Tj
0.9089 0 TD
( )Tj
0.275 0 TD
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odene. Be)14.8(g)-19.9(r)-19.6(unnelsene gir mulige Œrsak)9.7(er til at pasi-)]TJ
-1.6742 -1.2 TD
[(entoppholdene er k)9.7(odet feil. F)49.7(or Œ bedre k)9.7(odekv)24.8(aliteten)]TJ
T*
[(kan helseforetak)9.7(ene o)24.8(g)0( a)34.8(vdelingene derfor i)24.8(v)14.8(erksette til-)]TJ
T*
[(tak for Œ utn)24.8(ytte denne infor)-19.9(masjonen bedre.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 73.7953 511 Tm
0 0 0 1 k
/GS2 gs
-0.0112 Tc
0.0277 Tw
[(Helsefor)17.7(etakene gir ikke legene tilstr)17.8(ekkelig )]TJ
0 -1.3333 TD
-0.0113 Tc
[(oppl¾ring i gjeldende r)17.7(egelverk for koding)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 73.7953 487 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Unders¿k)9.7(elsen viser at le)14.8(gene mener at et k)9.7(ompliser)-19.9(t)]TJ
0 -1.2 TD
0 Tc
0 Tw
(f)Tj
0.3425 0 TD
-0.0001 Tc
0.025 Tw
[(agk)9.7(ode)24.8(v)14.8(erk o)24.8(g)0( mangelfull oppl¾ring er de viktigste)]TJ
-0.3425 -1.2 TD
[(Œrsak)9.7(ene til at k)9.7(o)-0.1(dingen ikk)9.7(e b)19.7(lir i samsv)24.8(ar med re)14.8(gel-)]TJ
T*
0 Tc
0 Tw
(v)Tj
0.4851 0 TD
-0.0001 Tc
0.0249 Tw
[(erk)9.7(et. Et k)9.7(ompliser)-19.9(t re)14.8(gelv)14.8(erk tilsier at systematisk)]TJ
-0.4851 -1.2 TD
[(oppl¾ring er helt n¿dv)14.8(endig for Œ sikre en god k)9.7(odekv)24.8(a-)]TJ
T*
[(litet. I sp¿r)-29.9(reskjemaunders¿k)9.7(elsen sv)24.8(arer hv)14.8(er tredje)]TJ
T*
[(le)14.8(ge at de ikk)9.7(e har fŒtt systematisk oppl¾ring i medi-)]TJ
T*
[(sinsk k)9.7(oding. )54.8(A)109.8(v)0( de som har fŒtt oppl¾ring, f)-59.9(ikk nesten)]TJ
T*
[(halvpar)-19.9(ten oppl¾ringen f¿r 2003. Mange le)14.8(ger har der-)]TJ
T*
[(for ikk)9.7(e oppdater)-19.9(t k)9.7(ompetanse i de medisinsk)9.7(e f)-9.9(agk)9.7(ode-)]TJ
T*
0 Tc
0 Tw
(v)Tj
0.4851 0 TD
-0.0001 Tc
[(erk)9.7(ene. )]TJ
-0.4851 -2.4 TD
0.025 Tw
[(Det er ledelsen i helseforetak)9.7(ene som har det o)44.8(v)14.8(erordne-)]TJ
0 -1.2 TD
[(de ansv)24.8(aret for at le)14.8(gene fŒr tilstrekk)9.7(elig oppl¾ring i)]TJ
T*
[(re)14.8(gelv)14.8(erk)9.7(et. I mange helseforetak er ansv)24.8(aret for oppl¾-)]TJ
T*
[(ringen dele)14.8(ger)-19.9(t til a)34.8(vdelingsleder)-19.9(ne. Det synes som om)]TJ
T*
[(den enk)9.7(elte a)34.8(vdelingsleders interesse for medisinsk)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(oding er a)34.8(vgj¿rende for hvilk)9.7(en oppl¾ring som gis den)]TJ
-0.4902 -1.2 TD
[(enk)9.7(elte le)14.8(ge. Unders¿k)9.7(elsen viser at det er n¿dv)14.8(endig)]TJ
T*
[(for foretaksledelsen Œ i)24.8(v)14.8(erksette tiltak som sikrer at opp-)]TJ
T*
[(l¾ringen i k)9.7(ode)24.8(v)14.8(erk)9.7(ene skjer pŒ en systematisk o)24.8(g)-0.1( k)9.7(oor-)]TJ
T*
[(diner)-19.9(t mŒte. F)49.7(oretaksledelsen har o)24.8(gsŒ ansv)24.8(ar for Œ etter-)]TJ
T*
[(pr¿v)14.8(e at bŒde de som k)9.7(oder o)24.8(g)-0.1( de som kv)24.8(alitetssikrer)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odingen, har n¿dv)14.8(endig o)24.8(g)0( oppdater)-19.9(t k)9.7(ompetanse i)]TJ
-0.4902 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
[(ode)24.8(v)14.8(erk)9.7(ene.)]TJ
-0.4902 -2.4 TD
0.025 Tw
[(Unders¿k)9.7(elsen viser at mange le)14.8(ger sjelden eller aldri)]TJ
0 -1.2 TD
[(fŒr indi)24.8(viduell tilbak)9.7(emelding pŒ k)9.7(odingen. Samtidig)]TJ
T*
[(mener mange le)14.8(ger at den tilbak)9.7(emeldingen som gis, i)]TJ
T*
[(stor g)-19.9(rad fremmer l¾ring som forbedrer k)9.7(odekv)24.8(aliteten.)]TJ
T*
[(Unders¿k)9.7(elsen indik)9.7(erer derfor et potensial for Œ he)24.8(v)14.8(e)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.0249 Tw
[(odekv)24.8(aliteten gjennom at den enk)9.7(elte le)14.8(ge fŒr mer indi-)]TJ
-0.4902 -1.2 TD
[(viduell tilbak)9.7(emelding pŒ k)9.7(odearbeidet. )]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 325.0787 799 Tm
0 0 0 1 k
/GS2 gs
-0.0112 Tc
0.0277 Tw
(Mange leger kjenner ikke godt nok til )Tj
0 -1.3333 TD
0 Tc
0 Tw
(r)Tj
0.36 0 TD
-0.0112 Tc
0.0277 Tw
(egelverket for medisinsk koding )Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 325.0787 775 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Le)14.8(gene mŒ kjenne til re)14.8(gelv)14.8(erk o)24.8(g)-0.1( v)14.8(eiledningsmateriale)]TJ
0 -1.2 TD
[(for Œ kunne k)9.7(ode riktig. Mangelfull oppl¾ring i medi-)]TJ
T*
[(sinsk k)9.7(oding er trolig en viktig Œrsak til at nesten 40)]TJ
T*
[(prosent a)34.8(v)0( le)14.8(gene i sp¿r)-29.9(reskjemaunders¿k)9.7(elsen sv)24.8(arer at)]TJ
T*
[(de ikk)9.7(e kjenner godt til k)9.7(ode)24.8(v)14.8(eiledningsmaterialet i)]TJ
T*
[(ICD-10-bok)9.7(en. Risik)9.7(o for feil k)9.7(oding forsterk)9.7(es v)14.8(ed at)]TJ
T*
[(enda f¾r)-29.9(re le)14.8(ger kjenner godt til annet sentralt k)9.7(ode)24.8(v)14.8(e)0.2(i-)]TJ
T*
[(ledningsmateriale. Mangelfull oppl¾ring er o)24.8(gsŒ med pŒ)]TJ
T*
[(Œ forklare at mange le)14.8(ger ikk)9.7(e synes Œ kjenne sentrale)]TJ
T*
[(prinsipper for k)9.7(oding. Dette gjelder bŒde assistentle)14.8(ger)]TJ
T*
-0.0249 Tc
0 Tw
(og)Tj
0.9751 0 TD
( )Tj
0.275 0 TD
-0.0449 Tc
(ov)Tj
0.9402 0 TD
-0.0002 Tc
[(erle)14.7(ger)54.7(. )]TJ
-2.1903 -2.4 TD
-0.0001 Tc
0.025 Tw
[(I perioden fra 2001 til 2003 har det v¾r)-19.9(t en sterk v)14.8(ekst i)]TJ
0 -1.2 TD
[(antall re)14.8(gistrer)-19.9(te bidiagnoser per pasientopphold. I jour-)]TJ
T*
[(nalre)24.8(visjonen b)19.7(le det funnet mange k)9.7(odede bidiagnoser)]TJ
T*
[(det ikk)9.7(e v)24.8(ar g)-19.9(r)-19.6(unnlag for i pasientjour)-19.9(nalen. Det er der-)]TJ
T*
[(for g)-19.9(r)-19.6(unn til Œ stille sp¿rsmŒl om k)9.7(odepraksisen a)34.8(v)0( bidi-)]TJ
T*
[(agnoser er i samsv)24.8(ar med re)14.8(gelv)14.8(erk)9.7(et. Unders¿k)9.7(elsen)]TJ
T*
[(viser at det er n¿dv)14.8(endig med tiltak for Œ fŒ en mer ens-)]TJ
T*
[(ar)-19.9(tet forstŒelse a)34.8(v)-0.1( hv)19.7(ordan re)14.8(gelv)14.8(erk)9.7(et for k)9.7(oding a)34.8(v)]TJ
T*
(bidiagnoser skal praktiseres.)Tj
0 -2.4 TD
[(Jour)-19.9(nalre)24.8(visjonen indik)9.7(er)-19.9(te at en Œrsak til sv)24.8(ak k)9.7(odekv)24.8(a-)]TJ
0 -1.2 TD
[(litet er at enk)9.7(elte le)14.8(ger kan ha ignorer)-19.9(t k)9.7(ode)24.8(v)14.8(eilednings-)]TJ
T*
[(infor)-19.9(masjonen som helseforetak)9.7(ene skal v¾re kjent)]TJ
T*
[(med. Det framgŒr a)34.8(v)0( sp¿r)-29.9(reskjemaunders¿k)9.7(elsen at)]TJ
T*
[(mange le)14.8(ger sv)24.8(arer at de ikk)9.7(e k)9.7(oder i samsv)24.8(ar med)]TJ
T*
[(re)14.8(gelv)14.8(erk)9.7(et i de tilfeller k)9.7(ode)24.8(v)14.8(erk)9.7(et er dŒrlig tilpasset)]TJ
T*
[(den medisinsk)9.7(e praksis. )]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 325.0787 415 Tm
0 0 0 1 k
/GS2 gs
-0.0112 Tc
0.0277 Tw
[(Koding og kvalitetssikring av kodingen )]TJ
0 -1.3333 TD
[(er ikke tilstr)17.7(ekkelig integr)17.7(ert i driften)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 325.0787 391 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(I sp¿r)-29.9(reskjemaunders¿k)9.7(elsen sv)24.8(arer 45 prosent a)34.8(v)]TJ
0 -1.2 TD
[(le)14.8(gene at manglende prioritering a)34.8(v)-0.1( k)9.7(odearbeidet er en)]TJ
T*
[(viktig Œrsak til la)34.8(v k)9.7(odekv)24.8(alitet. )49.7(T)35(idspress hos den)]TJ
T*
[(enk)9.7(elte le)14.8(ge kan f¿re til sv)24.8(ak k)9.7(odekv)24.8(alitet. Mange a)34.8(vde-)]TJ
T*
-0.0002 Tc
[(linger gir le)14.7(gene tilgang til en k)9.6(o)0(r)-20(tliste som viser de)]TJ
T*
-0.0001 Tc
[(mest br)-19.9(ukte k)9.7(odene i a)34.8(vdelingen. Br)-19.9(uk)9.7(en a)34.8(v)-0.1( k)9.7(o)0.1(r)-19.9(tliste)]TJ
T*
-0.0002 Tc
[(skal i utgangspunktet v¾re et hjelpemiddel for le)14.7(gene i)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odearbeidet. Unders¿k)9.7(elsen viser at 40 prosent a)34.8(v)]TJ
-0.4902 -1.2 TD
[(le)14.8(gene sjelden eller aldri slŒr opp i re)14.8(gelv)14.8(erk)9.7(et v)14.8(ed br)-19.9(uk)]TJ
T*
-0.0351 Tc
0 Tw
(av)Tj
0.9089 0 TD
( )Tj
0.275 0 TD
-0.0098 Tc
(ko)Tj
0.99 0 TD
(r)Tj
0.3528 0 TD
-0.0001 Tc
0.025 Tw
[(tliste. Dette f¿rer til at br)-19.9(uk)9.7(en a)34.8(v)-0.1( k)9.7(o)0.1(r)-19.9(tliste o)24.8(gsŒ)]TJ
-2.5267 -1.2 TD
0 Tc
0 Tw
(b)Tj
0.4802 0 TD
-0.0001 Tc
0.025 Tw
[(lir en forklaring til sv)24.8(ak k)9.7(odekv)24.8(alitet. )]TJ
-0.4802 -2.4 TD
[(Mange a)34.8(v)0( a)34.8(vdelingene i unders¿k)9.7(elsen er pŒ etterskudd)]TJ
0 -1.2 TD
[(med k)9.7(odingen o)24.8(g)-0.1( kv)24.8(alitetssikringen a)34.8(v)-0.1( denne.)]TJ
T*
0 Tc
0 Tw
(K)Tj
0.687 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(aliteten kan b)19.7(li bedre hvis le)14.8(gene k)9.7(oder for)-19.9(tl¿-)]TJ
-0.687 -1.2 TD
[(pende, under)-19.9(v)14.8(eis i pasientoppholdet, slik at skipper)-19.9(tak)]TJ
T*
[(unngŒs den dagen pasienten skri)24.8(v)14.8(es ut. Unders¿k)9.7(elsen)]TJ
T*
[(viser at helseforetak)9.7(ene ikk)9.7(e har etab)19.7(ler)-19.9(t gode nok r)-19.9(uti-)]TJ
T*
[(ner som sikrer k)9.7(o)-0.1(ding a)34.8(v)0( alle bidiagnoser det er g)-19.9(r)-19.6(unn-)]TJ
T*
[(lag for i jour)-19.9(nalen. )49.7(T)35(ilsv)24.8(arende viser unders¿k)9.7(elsen at)]TJ
T*
[(flere a)34.8(vdelinger ikk)9.7(e har etab)19.7(ler)-19.9(t r)-19.9(utiner som sikrer at)]TJ
T*
[(alle prosedyrer som er utf¿r)-19.9(t i andre a)34.8(vdelinger)39.7(, b)19.7(lir)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odet. Det er viktig for k)9.7(odekv)24.8(aliteten at det etab)19.7(leres)]TJ
-0.4902 -1.2 TD
0 Tc
0 Tw
(r)Tj
0.3525 0 TD
-0.0001 Tc
0.025 Tw
[(utiner som sikrer at k)9.7(oding o)24.8(g)-0.1( kv)24.8(alitetssikringen a)34.8(v)]TJ
-0.3525 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.0249 Tw
[(odingen i st¿r)-29.9(re g)-19.9(rad b)19.7(l)0(ir inte)14.8(g)-19.9(rer)-19.9(t i driften.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
7.5 0 0 7.5 73.7953 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0002 Tc
0 Tw
(49)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F1 1 Tf
7.5 0 0 7.5 415.4037 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0277 Tw
[(Dokument nr)91.7(. 3:7 \(2005Ð2006\) Rapport)]TJ
ET
Q
0 0 0 0 k
/GS2 gs
31 900.99 234 -10.99 re
f
BT
/F2 1 Tf
8 0 0 8 33 892 Tm
/Cs8 cs 1 scn
0.0099 Tc
0.0988 Tw
[(0272_RR_dok_3,7_innm 31.03.06 16:36 Side 49)]TJ
ET
1 G
0 J 0 j 0.5 w 10 M []0 d
1 i
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
/Cs8 CS 1 SCN
0.25 w
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
1 G
0.5 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
/Cs8 CS 1 SCN
0.25 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
endstream
endobj
49 1 obj
<<
/ProcSet [ /PDF /Text ]
/Font << /F1 8 0 R /F2 9 0 R /F3 41 1 R /F5 38 1 R >>
/ExtGState << /GS2 37 1 R >>
/ColorSpace << /Cs8 31 1 R >>
>>
endobj
50 1 obj
<<
/Type /Page
/Parent 100 0 R
/Resources 52 1 R
/Contents 51 1 R
/BleedBox [ 24 23 631 877 ]
/TrimBox [ 30 29 625 871 ]
/CropBox [ 29.76378 29.76378 625.23622 871.23622 ]
/MediaBox [ 0 0 655 901 ]
>>
endobj
51 1 obj
<< /Length 12957 >>
stream
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 101.8661 715 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Helse- o)24.8(g)0( omsor)17.7(gsdepar)-19.9(tementet er tilskuddsfor)-19.9(v)24.8(alter)]TJ
0 -1.2 TD
[(for ISF-ordningen, o)24.8(g)0( har derfor et o)44.8(v)14.8(erordnet ansv)24.8(ar)]TJ
T*
[(for at de re)14.8(gionale helseforetak)9.7(ene har en tilfredsstil-)]TJ
T*
[(lende inter)-19.9(nk)9.7(ontroll som b)19.7(lant annet sikrer en k)9.7(o)0.1(r)-29.9(rekt)]TJ
T*
[(medisinsk k)9.7(oding a)34.8(v)0( pasientbehandlingen i helseforeta-)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ene. Depar)-19.9(tementet har de siste Œrene i)24.8(v)14.8(erksatt en)]TJ
-0.4902 -1.2 TD
[(rekk)9.7(e tiltak for Œ bedre kv)24.8(aliteten pŒ den medisinsk)9.7(e)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0002 Tc
0.0251 Tw
[(odingen. F)49.6(or eksempel er det igangsatt et samarbeids-)]TJ
-0.4902 -1.2 TD
-0.0001 Tc
[(prosjekt med Le)14.8(geforeningen o)24.8(g)0( de ulik)9.7(e spesialfor-)]TJ
T*
[(eningene for Œ fŒ en felles forstŒelse o)24.8(g)0( f)-9.9(aglig enighet)]TJ
T*
[(om k)9.7(odingen. Det er sentralt at disse tiltak)9.7(ene l)24.8(ykk)9.7(es,)]TJ
T*
[(siden en enhetlig o)24.8(g)-0.1( k)9.7(o)0.1(r)-29.9(rekt k)9.7(odepraksis er a)34.8(vgj¿rende)]TJ
T*
[(for at f)-59.9(inansieringsordningen skal ha n¿dv)14.8(endig le)14.8(giti-)]TJ
T*
0 Tw
(mitet. )Tj
0 -2.4 TD
0.025 Tw
[(Unders¿k)9.7(elsen viser at styrene o)24.8(g)0( ledelsen i helseforeta-)]TJ
0 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ene ikk)9.7(e i tilstrekk)9.7(elig g)-19.9(rad har i)24.8(v)24.8(aretatt sitt ansv)24.8(ar)]TJ
-0.4902 -1.2 TD
[(med Œ etab)19.7(lere systemer som sikrer en god k)9.7(odekv)24.8(alitet.)]TJ
T*
[(Mangelfull oppl¾ring i gjeldende re)14.8(gelv)14.8(erk for medi-)]TJ
T*
[(sinsk k)9.7(oding er en viktig Œrsak til en sv)24.8(ak k)9.7(odekv)24.8(alitet.)]TJ
T*
0 Tc
0 Tw
(V)Tj
0.6821 0 TD
-0.0001 Tc
0.025 Tw
[(idere har flere a)34.8(v)0( helseforetak)9.7(ene i unders¿k)9.7(elsen ikk)9.7(e)]TJ
-0.6821 -1.2 TD
[(utarbeidet retningslinjer for hv)19.7(ordan re)14.8(gelv)14.8(erk)9.7(et skal)]TJ
T*
[(etterle)24.8(v)14.8(es. I tille)14.8(gg har helseforetak)9.7(ene i unders¿k)9.7(elsen)]TJ
T*
[(lite systematisk oppf¿lging a)34.8(v)0( utviklingen i k)9.7(odekv)24.8(alite-)]TJ
T*
-0.0002 Tc
[(ten. Unders¿k)9.6(elsen viser at ledelsens engasjement pŒ)]TJ
T*
-0.0001 Tc
[(omrŒdet har a)34.8(vgj¿rende betydning for k)9.7(odekv)24.8(aliteten i)]TJ
T*
0 Tw
[(helseforetak)9.7(et. )]TJ
0 -2.4 TD
0.025 Tw
[(En sv)24.8(ak k)9.7(odekv)24.8(alitet kan pŒ en utilsiktet mŒte pŒvirk)9.7(e)]TJ
0 -1.2 TD
[(ressursfordelingen mellom bŒde helseforetak)9.7(ene o)24.8(g)]TJ
T*
0 Tc
0 Tw
(a)Tj
0.4089 0 TD
-0.0001 Tc
0.025 Tw
[(vdelingene i det enk)9.7(elte helseforetak. )49.7(V)39.8(idere sv)14.8(ekk)9.7(er)]TJ
-0.4089 -1.2 TD
[(en sv)24.8(ak k)9.7(odekv)24.8(alitet muligheten til Œ oppnŒ en forsv)24.8(ar-)]TJ
T*
[(lig ¿k)9.7(onomistyring i helseforetak)9.7(ene. Depar)-19.9(tementet har)]TJ
T*
[(et o)44.8(v)14.8(erordnet ansv)24.8(ar for at de re)14.8(gionale helseforetak)9.7(ene)]TJ
T*
[(f¿lger de nasjonale retningslinjene i prioriteringen a)34.8(v)]TJ
T*
[(pasientene. Unders¿k)9.7(elsen gir ikk)9.7(e klare holdepunkter)]TJ
T*
[(for at ISF-ordningen bidrar til nedprioritering a)34.8(v)0( pasien-)]TJ
T*
[(ter i helseforetak)9.7(ene a)34.8(v)-0.1( ¿k)9.7(onomisk)9.7(e Œrsak)9.7(er)54.8(.)]TJ
ET
0 0 0 1 K
0 J 0 j 0.3 w 10 M []0 d
101.87 246.49 m
330.47 246.49 l
S
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 101.8661 235 Tm
0 1 0.65 0.34 k
/GS2 gs
-0.0001 Tc
0.0278 Tw
(9.1 rsaker til svak kodekvalitet)Tj
0 0 0 1 k
0 -2.6667 TD
-0.0112 Tc
[(Helsefor)17.7(etakene har lite systematisk styring )]TJ
0 -1.3333 TD
(av kodekvaliteten )Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 101.8661 187 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(De fleste helseforetak)9.7(ene i unders¿k)9.7(elsen har gjennom-)]TJ
0 -1.2 TD
[(f¿r)-19.9(t en rekk)9.7(e tiltak i l¿pet a)34.8(v)0( de siste Œrene for Œ bedre)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(aliteten. Disse tiltak)9.7(ene har trolig f¿r)-19.9(t til en bedre)]TJ
-0.4902 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(alitet b)19.7(lant annet gjennom en mer fullstendig)]TJ
-0.4902 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(oding a)34.8(v)0( diagnoser o)24.8(g)0( prosedyrer)54.8(. Unders¿k)9.7(elsen viser)]TJ
-0.4902 -1.2 TD
[(lik)9.7(e)25(v)14.8(el at det for)-19.9(tsatt er beho)44.8(v for at styrene o)24.8(g)0( ledelsen)]TJ
T*
[(i helseforetak)9.7(ene i)24.8(v)14.8(erksetter ytterligere tiltak for Œ sikre)]TJ
T*
[(en bedre inter)-19.9(n k)9.7(ontroll. )]TJ
25.1283 61.2 TD
[(Ledelsen v)14.8(ed alle helseforetak)9.7(ene i unders¿k)9.7(elsen pek)9.7(er)]TJ
0 -1.2 TD
[(pŒ at de har en mŒlsetting om at k)9.7(odingen skal v¾re)]TJ
T*
-0.0098 Tc
0 Tw
(ko)Tj
0.99 0 TD
(r)Tj
0.3628 0 TD
-0.0001 Tc
0.025 Tw
[(rekt. Unders¿k)9.7(elsen viser lik)9.7(e)25(v)14.8(el at det er mangler i)]TJ
-1.3528 -1.2 TD
[(styringen i o)24.8(g)0( med at ingen a)34.8(v)0( helseforetak)9.7(ene i inter-)]TJ
T*
[(vjuunders¿k)9.7(elsen har utviklet mŒl som gj¿r det mulig Œ)]TJ
T*
[(etter)-29.9(pr¿v)14.8(e om ¿nsk)9.7(et k)9.7(odekv)24.8(alitet er nŒdd. )]TJ
0 -2.4 TD
[(I helseforetak)9.7(ene, bŒde sentralt o)24.8(g)0( ute i a)34.8(vdelingene,)]TJ
0 -1.2 TD
[(gjennomf¿res en l¿pende vurdering a)34.8(v)0( forhold som kan)]TJ
T*
[(pŒvirk)9.7(e k)9.7(odekv)24.8(aliteten. Dette f¿rer b)19.7(lant annet til at)]TJ
T*
[(mindre erf)-9.9(ar)-19.9(ne le)14.8(ger b)19.7(lir gjenstand for en mer omf)-9.9(at-)]TJ
T*
[(tende k)9.7(ontroll enn mer erf)-9.9(ar)-19.9(ne le)14.8(ger)54.8(. Unders¿k)9.7(elsen)]TJ
T*
[(viser lik)9.7(e)25(v)14.8(el at ingen a)34.8(v)0( helseforetak)9.7(ene systematisk har)]TJ
T*
[(anal)24.8(yser)-19.9(t forhold som kan hindre at den medisinsk)9.7(e)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odingen utf¿res i samsv)24.8(ar med gjeldende re)14.8(gelv)14.8(erk.)]TJ
-0.4902 -1.2 TD
[(Dette reduserer foretaksledelsens mulighet til Œ etab)19.7(lere)]TJ
T*
[(tiltak o)24.8(g)0( r)-19.9(utiner for Œ hŒndtere disse risik)9.7(oene. )]TJ
9.8 0 0 10 353.1496 499 Tm
[(Ledelsesrappor)-19.9(tene i helseforetak)9.7(ene inneholder i liten)]TJ
T*
0 Tc
0 Tw
(g)Tj
0.5198 0 TD
-0.0001 Tc
0.025 Tw
[(rad infor)-19.9(masjon som bel)24.8(yser k)9.7(odekv)24.8(aliteten. De fleste)]TJ
-0.5198 -1.2 TD
[(ledelsesrappor)-19.9(tene presenterer antall pasientopphold i)]TJ
T*
(DRG 470. Dette er pasientopphold som er mangelfullt)Tj
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odet, o)24.8(g)0( som ikk)9.7(e)0( gir helseforetak)9.7(ene inntekter)54.8(. Et hel-)]TJ
-0.4902 -1.2 TD
[(seforetak eller en a)34.8(vdeling med fŒ eller ingen pasientopp-)]TJ
T*
[(hold i DRG 470 har imidler)-19.9(tid ikk)9.7(e n¿dv)14.8(endigvis god)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(alitet, jf. resultatene fra jour)-19.9(nalre)24.8(visjonen. Mangel)]TJ
-0.4902 -1.2 TD
[(pŒ etter)-29.9(pr¿vbare mŒl o)24.8(g)0( rappor)-19.9(tering pŒ k)9.7(odekv)24.8(aliteten)]TJ
T*
[(vil gj¿re det v)24.8(ansk)9.7(elig for styrene o)24.8(g)0( ledelsen i helsefore-)]TJ
T*
[(tak)9.7(ene Œ o)44.8(v)14.8(er)-19.9(vŒk)9.7(e hv)19.7(or ef)24.8(fekti)24.8(vt o)24.8(g)0( hensiktsmessig k)9.7(on-)]TJ
T*
[(trollakti)24.8(vitetene fungerer i forhold til o)44.8(v)14.8(erholdelse a)34.8(v)]TJ
T*
[(gjeldende re)14.8(gelv)14.8(erk. Et helseforetak skiller se)14.8(g positi)24.8(vt ut)]TJ
T*
0 Tc
0 Tw
(v)Tj
0.4851 0 TD
-0.0001 Tc
0.025 Tw
[(ed at ledelsen fŒr tilbak)9.7(emelding om utviklingen i)]TJ
-0.4851 -1.2 TD
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(odekv)24.8(aliteten v)14.8(ed at det hv)14.8(er)-19.9(t Œr gjennomf¿res en jour-)]TJ
-0.4902 -1.2 TD
[(nalre)24.8(visjon a)34.8(v)0( et utv)24.8(alg pasientopphold. )]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
9 0 0 9 353.1496 295 Tm
0 0 0 1 k
/GS2 gs
-0.0112 Tc
0.0277 Tw
[(Helsefor)17.7(etakene mangler r)17.7(etningslinjer )]TJ
0 -1.3333 TD
[(for hvor)17.7(dan r)17.7(egelverket skal etterleves)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
9.8 0 0 10 353.1496 271 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Helseforetak)9.7(ene har plikt til Œ s¿r)17.7(ge for at a)34.8(vdelingene)]TJ
0 -1.2 TD
[(har tilfredsstillende r)-19.9(utiner for k)9.7(oding slik at feil a)34.8(v)0(dek-)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(es o)24.8(g)-0.1( k)9.7(o)0.1(r)-29.9(rigeres. NŒr ansv)24.8(aret for k)9.7(odekv)24.8(aliteten dele)14.8(ge-)]TJ
-0.4902 -1.2 TD
[(res til a)34.8(vdelingsleder)39.7(, har foretaksledelsen o)24.8(gsŒ et ansv)24.8(ar)]TJ
T*
[(for Œ se etter om det er etab)19.7(ler)-19.9(t r)-19.9(utiner som sikrer en til-)]TJ
T*
[(fredsstillende k)9.7(odekv)24.8(alitet. I tre a)34.8(v)0( sju helseforetak i)]TJ
T*
[(inter)-19.9(vjuunders¿k)9.7(elsen f)-59.9(innes det skriftlige ansv)24.8(arsbeskri-)]TJ
T*
0 Tc
0 Tw
(v)Tj
0.4851 0 TD
-0.0001 Tc
0.025 Tw
[(elser for k)9.7(ode- o)24.8(g)0( re)14.8(gistreringspersonell. K)24.8(un i ett a)34.8(v)]TJ
-0.4851 -1.2 TD
[(helseforetak)9.7(ene f)-59.9(innes det skriftlige r)-19.9(utiner som beskri)24.8(v)14.8(e)0.3(r)]TJ
T*
[(ansv)24.8(ar o)24.8(g)0( m)39.7(yndighet hos de ulik)9.7(e personellg)-19.9(r)-19.6(uppene som)]TJ
T*
[(er in)39.7(v)19.7(olv)14.8(er)-19.9(t i k)9.7(odearbeidet. Mange helseforetak i inter-)]TJ
T*
[(vjuunders¿k)9.7(elsen har med andre ord ikk)9.7(e utarbeidet)]TJ
T*
[(skriftlige retningslinjer for hv)19.7(ordan de medisinsk)9.7(e re)14.8(gel-)]TJ
T*
0 Tc
0 Tw
(v)Tj
0.4851 0 TD
-0.0001 Tc
0.025 Tw
[(erk)9.7(ene skal etterle)24.8(v)14.8(es. Dette f¿rer til at k)9.7(odekv)24.8(aliteten i)]TJ
-0.4851 -1.2 TD
[(en a)34.8(vdeling b)19.7(lir sv¾r)-19.9(t a)34.8(vhengig a)34.8(v)0( a)34.8(vdelingslederens)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ompetanse, interesse o)24.8(g)0( moti)24.8(v)24.8(asjon )]TJ
10 0 0 10 499.9878 91 Tm
0 Tc
[(for k)9.8(oding.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
7.5 0 0 7.5 101.8661 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0002 Tc
0 Tw
(48)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F1 1 Tf
7.5 0 0 7.5 443.4746 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0277 Tw
[(Dokument nr)91.7(. 3:7 \(2005Ð2006\) Rapport)]TJ
ET
0 0 0 0 k
100.87 814.31 481.89 -85.32 re
f
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
14 0 0 14 101.8661 799 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0278 Tw
[(9 V)36.8(u)0.1(r)17.7(deringer)]TJ
ET
Q
0 0 0 0 k
/GS2 gs
31 900.99 234 -10.99 re
f
BT
/F2 1 Tf
8 0 0 8 33 892 Tm
/Cs8 cs 1 scn
0.0099 Tc
0.0988 Tw
[(0272_RR_dok_3,7_innm 31.03.06 16:36 Side 48)]TJ
ET
1 G
0 J 0 j 0.5 w 10 M []0 d
1 i
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
/Cs8 CS 1 SCN
0.25 w
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
1 G
0.5 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
/Cs8 CS 1 SCN
0.25 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
endstream
endobj
52 1 obj
<<
/ProcSet [ /PDF /Text ]
/Font << /F1 8 0 R /F2 9 0 R /F3 41 1 R /F5 38 1 R >>
/ExtGState << /GS2 37 1 R >>
/ColorSpace << /Cs8 31 1 R >>
>>
endobj
53 1 obj
<<
/Type /Page
/Parent 119 0 R
/Resources 55 1 R
/Contents 54 1 R
/BleedBox [ 24 23 631 877 ]
/TrimBox [ 30 29 625 871 ]
/CropBox [ 29.76378 29.76378 625.23622 871.23622 ]
/MediaBox [ 0 0 655 901 ]
>>
endobj
54 1 obj
<< /Length 8736 >>
stream
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 73.7953 799 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(stilt flere andre kra)34.8(v v)14.8(edr¿rende ISF-ordningen i sty-)]TJ
0 -1.2 TD
(ringsdokumentene for 2004:)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 763.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 763 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Budsjettet for 2004 le)14.8(gger til rette for en videref¿ring)]TJ
0 -1.2 TD
-0.0351 Tc
0 Tw
(av)Tj
0.9088 0 TD
( )Tj
0.2749 0 TD
-0.0001 Tc
0.025 Tw
[(akti)24.8(viteten pŒ om lag samme h¿y)19.7(e ni)24.8(vŒ som akti-)]TJ
-1.1837 -1.2 TD
(viteten i 2003.)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 727.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 727 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Helseforetak)9.7(ene mŒ for)-19.9(tsatt ha oppmerksomhet mot Œ)]TJ
0 -1.2 TD
[(holde v)14.8(entelistene pŒ et la)34.8(vt ni)24.8(vŒ.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 703.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 703 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(ISF-systemet skal ikk)9.7(e v¾re styrende for de priorite-)]TJ
0 -1.2 TD
[(ringene som gj¿res med hensyn til hvilk)9.7(e pasienter)]TJ
T*
[(som skal tilb)24.8(ys behandling. De re)14.8(gionale helseforeta-)]TJ
T*
0 Tc
0 Tw
(k)Tj
0.4902 0 TD
-0.0001 Tc
0.025 Tw
[(ene mŒ derfor b)19.7(lant annet se til at de a)34.8(vtalene som)]TJ
-0.4902 -1.2 TD
[(inngŒs med helseforetak o)24.8(g)0( pri)24.8(v)24.8(ate tjenestele)24.8(v)14.8(erand¿-)]TJ
T*
[(rer)39.7(, er a)34.8(v)0( en slik karakter at det ikk)9.7(e medf¿rer uheldi-)]TJ
T*
[(ge prioriteringer)54.8(.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 619.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 619 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
(Refusjonene gjennom ISF-systemet skal baseres pŒ)Tj
0 -1.2 TD
[(reell akti)24.8(vitet,)-275.1(o)24.8(g)0( skal f)-9.9(astsettes i samsv)24.8(ar med dette i)]TJ
T*
[(forbindelse med endelig a)34.8(vre)14.8(gning vŒren 2005.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 583.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 583 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0249 Tw
[(De re)14.8(gionale helseforetak)9.7(ene skal etab)19.7(lere et system)]TJ
0 -1.2 TD
[(som sikrer at lo)44.8(v)14.8(er o)24.8(g)0( forskrifter)39.7(, her)-19.9(under retningslin-)]TJ
T*
[(jer for k)9.7(oding, f¿lges i virksomheten.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 547.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 547 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Det for)-19.9(v)14.8(entes at de re)14.8(gionale helseforetak)9.7(ene etab)19.7(lerer)]TJ
0 -1.2 TD
0 Tc
0 Tw
(r)Tj
0.3525 0 TD
-0.0001 Tc
0.025 Tw
[(utiner som sikrer en mest mulig enhetlig k)9.7(oding i)]TJ
-0.3525 -1.2 TD
[(samarbeid med b)19.7(lant annet Le)14.8(geforeningen.)]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F9 1 Tf
8 0 0 8 73.7953 511.5 Tm
0 0 0 1 k
/GS2 gs
0 Tc
0 Tw
(€)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F3 1 Tf
10 0 0 10 81.4203 511 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.025 Tw
[(Det for)-19.9(utsettes at de re)14.8(gionale helseforetak)9.7(ene deltar)]TJ
0 -1.2 TD
[(akti)24.8(vt i det nasjonale utviklings- o)24.8(g)0( gjennomf¿rings-)]TJ
25.1283 30 TD
[(arbeidet v)14.8(edr¿rende retningslinjer for k)9.7(o)0.1(r)-29.9(rekt o)24.8(g)0( ens-)]TJ
0 -1.2 TD
[(ar)-19.9(tet k)9.7(oding, b)19.7(lant annet gjennom seminar rettet mot)]TJ
T*
[(jour)-19.9(nalansv)24.8(arlige i helseforetak)9.7(ene. )]TJ
-0.7625 -2.4 TD
[(I Œrlig melding for 2004 rappor)-19.9(terer de re)14.8(gionale helse-)]TJ
0 -1.2 TD
[(foretak)9.7(ene om utviklingen i akti)24.8(vitet o)24.8(g)-0.1( v)14.8(e)0.1(ntetider)39.7(, men)]TJ
T*
[(det rappor)-19.9(teres i be)14.8(g)-19.9(renset g)-19.9(rad om hv)19.7(ordan utviklingen)]TJ
T*
[(har v¾r)-19.9(t for de ulik)9.7(e pasientg)-19.9(r)-19.6(uppene. NŒr det gjelder)]TJ
T*
[(prioriteringsprob)19.7(lematikk, rappor)-19.9(terer Helse Nord RHF)]TJ
T*
[(om enk)9.7(elte omrŒder hv)19.7(or de har henholdsvis o)44.8(v)14.8(er)19.7(- o)24.8(g)]TJ
T*
[(underkapasitet. Ingen a)34.8(v)0( de re)14.8(gionale helseforetak)9.7(ene)]TJ
T*
[(rappor)-19.9(terer pŒ hvilk)9.7(en mŒte ISF-ordningen har bidratt til)]TJ
T*
[(Œ kar)-19.9(tle)14.8(gge k)9.7(ostnader o)24.8(g)0( til Œ fjer)-19.9(ne flask)9.7(ehalser som)]TJ
T*
[(hindrer ef)24.8(fekti)24.8(v pasientbehandling. )49.7(V)39.8(idere har de re)14.8(gio-)]TJ
T*
[(nale helseforetak)9.7(ene i Œrlig melding i liten g)-19.9(rad rede-)]TJ
T*
[(gjor)-19.9(t for hv)19.7(ordan de har gjennomf¿r)-19.9(t depar)-19.9(tementets)]TJ
T*
0 Tc
[(kra)34.9(v v)14.9(edr¿rende k)9.8(oding. )49.7(V)110.9(edtatt budsjett for 2004 for)-19.8(ut-)]TJ
T*
-0.0001 Tc
[(satte om lag uendret akti)24.8(vitet fra 2003 til 2004. Det)]TJ
T*
[(framgŒr a)34.8(v)0( St.pr)-29.9(p. nr)54.8(. 1 \(2005Ð2006\) at den reelle v)14.8(e)0(k-)]TJ
T*
[(sten i 2004 v)24.8(ar pŒ om lag Žn prosent.)]TJ
0 -2.4 TD
[(I styringsdokumentene til de re)14.8(gionale helseforetak)9.7(ene)]TJ
0 -1.2 TD
[(for 2005 ba depar)-19.9(tementet de re)14.8(gionale helseforetak)9.7(ene)]TJ
T*
(om Œ ha et ledelsesmessig fokus pŒ arbeidet med Œ)Tj
T*
[(h¿yne kv)24.8(aliteten pŒ den medisinsk)9.7(e k)9.7(odingen. )]TJ
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F5 1 Tf
7.5 0 0 7.5 73.7953 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0002 Tc
0 Tw
(47)Tj
ET
Q
q
1 i
0 901 655 -901 re
0 901 m
W n
0.015 900.99 654.99 -900.99 re
W n
BT
/F1 1 Tf
7.5 0 0 7.5 415.4037 57.2186 Tm
0 0 0 1 k
/GS2 gs
-0.0001 Tc
0.0277 Tw
[(Dokument nr)91.7(. 3:7 \(2005Ð2006\) Rapport)]TJ
ET
Q
0 0 0 0 k
/GS2 gs
31 900.99 234 -10.99 re
f
BT
/F2 1 Tf
8 0 0 8 33 892 Tm
/Cs8 cs 1 scn
0.0099 Tc
0.0988 Tw
[(0272_RR_dok_3,7_innm 31.03.06 16:36 Side 47)]TJ
ET
1 G
0 J 0 j 0.5 w 10 M []0 d
1 i
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
/Cs8 CS 1 SCN
0.25 w
30 901 m
30 877 l
0 871 m
24 871 l
625 901 m
625 877 l
655 871 m
631 871 l
30 -1 m
30 23 l
0 29 m
24 29 l
625 -1 m
625 23 l
655 29 m
631 29 l
S
1 G
0.5 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
/Cs8 CS 1 SCN
0.25 w
303.5 889 m
351.5 889 l
303.5 11 m
351.5 11 l
12 474 m
12 426 l
643 474 m
643 426 l
327.5 901 m
327.5 877 l
327.5 23 m
327.5 -1 l
0 450 m
24 450 l
631 450 m
655 450 l
327.5 889 m
333.5 889 l
333.5 885.688 330.812 883 327.5 883 c
324.188 883 321.5 885.688 321.5 889 c
321.5 892.312 324.188 895 327.5 895 c
330.812 895 333.5 892.312 333.5 889 c
327.5 11 m
333.5 11 l
333.5 7.688 330.812 5 327.5 5 c
324.188 5 321.5 7.688 321.5 11 c
321.5 14.312 324.188 17 327.5 17 c
330.812 17 333.5 14.312 333.5 11 c
12 450 m
18 450 l
18 446.688 15.312 444 12 444 c
8.688 444 6 446.688 6 450 c
6 453.312 8.688 456 12 456 c
15.312 456 18 453.312 18 450 c
643 450 m
649 450 l
649 446.688 646.312 444 643 444 c
639.688 444 637 446.688 637 450 c
637 453.312 639.688 456 643 456 c
646.312 456 649 453.312 649 450 c
S
endstream
endobj
55 1 obj
<<
/ProcSet [ /PDF /Text ]
/Font << /F1 8 0 R /F2 9 0 R /F3 41 1 R /F5 38 1 R /F9 56 1 R >>
/ExtGState << /GS2 37 1 R >>
/ColorSpace << /Cs8 31 1 R >>
>>
endobj
56 1 obj
<<
/Type /Font
/Subtype /Type1
/FirstChar 0
/LastChar 255
/Widths [ 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 250
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 460
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 600
600 600 600 600 600 600 600 600 600 600 600 600 600 600 600 ]
/Encoding 60 1 R
/BaseFont /Symbol
/FontDescriptor 58 1 R
/ToUnicode 57 1 R
>>
endobj
57 1 obj
<< /Filter [ /ASCII85Decode /FlateDecode ] /Length 286 >>
stream
8;U<-Z#7K&%#/tt_W.1J5aY_(b&ULY%)#]d[6"UgMUWL(O@U>D+M%StOKh]M3`RURb*^RGhRY'$`Y"!SUSqO'Gp&DfBrH
H;I+nDsWQK9lRU!T3k_HlbMI-jQY45Z^DD9_>^gb((kZ5Rsf6p\3shh
%8@,1
endstream
endobj
58 1 obj
<<
/Type /FontDescriptor
/Ascent 0
/CapHeight 0
/Descent 0
/Flags 4
/FontBBox [ -167 -299 1063 827 ]
/FontName /Symbol
/ItalicAngle 0
/StemV 0
/FontFile3 59 1 R
>>
endobj
59 1 obj
<< /Filter [ /ASCII85Decode /FlateDecode ] /Length 30523 /Subtype /Type1C >>
stream
8;U#?HW1Y[)S^K.1.9(UN6igsBU)WaMq7&@Lff^,hXV505UX[8$qt9QGo/f2U-3\#
=P[#9(/Z3V#[!4A8p@m2=$0L7h,Cr+9c;+/[g/6F[0$KWAKC9S>tk($<:5k^Y2uTEeN6)RpT4"@%I0_TuX,]F8_rHgh(6(]50M
JrRfW_TZ*j[LcZ"D87p3I#Q';Z#XXkFo\S`>-Kg8(YD0X#J5om'75?(@7*#7:V`mg
Zg`\D$@G".MP#OD#b?M+bd0Np#2^=N5;TOd6`E>KA6EX)Q9@>*LG$/nZGtk%'3U-,o;8
?'J$V"-J_ggm%02oB;WpT!)]/(R7P7e2eE;-I']_H9l"BT$)(-)^r1b=t`fG]Sp_N
8Sg..#ZM/m[Q19c,u$sT1Nj@%R;DQ\-5W;n38IOlV;qbh81KTnGLK;:O3*J#.iem@
dNuOs$a_>/S:e's/1$/f!ifs,[:;Qb]8L[-G3E<^_8SB646R!'ll[3NVOCoqAiPJT
=qR-P;:3>fhCVZ`'"lPk-=R'm3J3>AO\0*<%!qYo7H?gjA).Qka>?O_'"q;==GA>7
3(C'TZ\m#D:i;kG\7eL!-%U*0?0".,*bA@U/6sG)J0G+SO`@sa#7fV.8Mj&L!u6\[
,m]/>6see?RGg/Z;+OY6#?+O;nT*PB>*s/?j6SW!9T^t=S-IuHqT:3`.Wk2)qN>k\
+q3S/K7/8f$*L':OX`_7;eYpP$u-/QUa4(-Lj#)-/$-r#CdjElX![dgDGd);)6t+c.)1h,)UHIZr8P9+sQDR
gD!'hR1_S7f_AOP\K"=iS'adWUl9/8eKlm,=[)k4g
ZBrsZ:bmdPj^UhX7_]K`qND7B\?72-?kCZ73Aa?Pka_U?:._[_C.CKG16)E26_NH*:]GE6)nh@Yk]n`,;8
#u>Z,FKaq,-\bEuR\ZADB_'-a5>5dY\p`j.VOa7N<'N/::1RU?:K2/[h3TP-7`.%B
3b*qZm>T+(^#j?ne'_s@'jV`k/%Qo#9_@G7HY0fpT)#[1p4G@e@q&oY@esHBq.f6N
%J-IB47QMHr+YcK/QfRAa+[6G8esKuP@":cNKtkLQf]oC/aZc.]'S\PZcaGod'$QY
14829?i@Ve@TEBl/ZTglhcehP(EJh^pI3l4ppBgrq"?S[:.S!U8Jk\O\(6[$-*]82
-h70sm@3^uT@qSQAD&pm3@Z=;Kh8h;3]m"">"mZ<[%Gcf1Vts-1L-E.=]BQJp5\LJ
m"a9m3Q@RH3QH4/k>'8rbC)VL6LJ4OaSa9[KD>W#V:HpX]@LKCZdu=]_ZcM;RL7>Y
fsAY%\?W95n645?7J7p$dCH"+71Y:PMO,$,:jfCTa58U2kTA3A_K7#X9YUN9*XWjS
Bd2m9"!+7iDhgDJjBPSqnk[Z$#,?8bg
8RA`)ip+[FAc,:pZ:ND*I$oPfj1UVdheF@8o_UkPXfnkYU?,L0TtBHoVqKkliTb)$
buMq.Masp!/N-SrX/rE[f2h=s^441I_lZf!aSu[UC35qnHNsJMpD&g>cgVACp44)"
5OTQZWkY]o3lt*2n4lm54+2&[Z8H+]-P,8KV$olj'*]Y9Fq$8,'N3PTCXW,p@%tB7
[&uC/OT/(Y-d1l0`+M/Q9+.8'XD#)kF>[oWnfKf;/DHV.g:@^U&,kqk-$-uC[ThS$
^V,-j9'^-DcVCki4_*h<ID@FYUb3MT"/mJQrfU:bUe%omaeu:p+!]%c5gdhV/35I
5ArN*q"IM7c&I3ds5Won54:Mfh;5#GCMTpL5E4bGe5UV3EU0(SY&)eB2AXS0mi=g9
a+t4+Xb(X`g]aM4*=sI!"Nj&%#UJAo5`gL,"p>6!#f.(h96n&<'OjJk-*UG7.dB?5
\uY1r@lnR6HU:K_l,@B"2rDBqDs!SIo5i.+coh!8gIEj9I`u1ThB1&m8I^=9LV=bT0A"is2IsO5QC*f/>sTZjla'h]A;`P;#e"kNhS32O-5d5e2o`
L).1"drpHoC[4+?"c!:8lM@K/?,*YJj8Bh8rf)j-ng_O`_H'md%.o.`]$^4hZFdfr
@"gOc52mdD`QjbjBbg4%5O(ECrO($[`+$$Tim\S]7H[lr399YYJ@W]IL
rt$_0`Y86jl\V<)?b#u/,&RZ$nn552-P0;bCQlin,XZZh&GGVNE\uF0#keoPg&lM?
*M*cf6g)4NTQTbG@mfu8l;@;(bM;G`n0EKM7#320$7p.Bgi/PHP-/#5`ZIj#>uKZ<
,`3e?8=ig.L8SJhf-7/L?J`qo\[eOAs&h`0!c\ttgn0A06]S:*b^m*kR\h:'WN\9^
$K@;4U&\(*ODlc!0BClTLIltAS/nZO1P^C]^[Ks#Lr.QJiK^n%gZN)1fB<3"qfle<
gBtLNL:<6%#Uk]r>BYrTf9DSnKiJ/N9%kb"/"2G47Yj1RH7Hm-a+;o,(4/HF?.$[b4M5cH6[#:ok`+LVoa`-L[)1l0t[QtC5SrMR]nTkUl
YRa#mL]_T1^eoM>E!^lT9DB'm&()0eJKYiRpsC$@nIZmWaj>$l#>hQ@"^)ClZlll;
S.O`8a3JSi6MN0!"HJ.#o_3$/6cO'THh7a1Ac96@AEQci0^P7dJhZ+<$Z)7!hN^>B4M1a]&MCfKQIb$fI28\U'[
jd4+G6%3+F3K.b\X69#(P'+(tjDaGo0bZ(IRKhl!)O6I`W\jMY+P5`oP[n9T=l#q%
T%BSnSUYt^Smkq=P57VmB4]6W`T:[m,#,L,^OXBYd,`8uU*d(;OAn)B/iCKEiN':c
auX;U)JpeMX;H)5/,,b1Op-0,`XLU\[7ts>hkY,V!Y+FujAVjjWq_Sh
(g%R5?n/]lcp["8j>sQSKLUWhnut$N3P&k3pKmHC
Q>g1/V4GrPP[gn,4/QiK*IAB0gM>Pu.*"7#?7$+8oJ(g?IW=Cdj-I<1A^:3]&PT3B
LqCb]Z+pnQ"et!]RU!DgbVUHRP\nVlo8W,`4n+W;U/Fcel7Z.:6XB)i1Dd%UZPSLa
5a\%&Ef*PNO6$3.4#:-3mEIO>qr^4@a-D@&a,I/2MgT:.iFPq.K`J308!XjtHhRMs72&XT$";@F?`Yr6[,ThY74._pC#l
gsPt$[-9%4"E!G!];c,Z8M]l,70JGQ?bCh+DhWEdhS@+U5*S!L(?-Q@$?4C8I-`<=
8D;earTp]t?)Cn\!'e]JM5agW=))]e-hKMbqC71kH'sHccinql0-d+'=6-ErH^5K;
q4,7t3jhH-0Q_lZ].c??:m'ngX6.O.Go[>SXK736Y.kjbCajL
_eYHk5.3DVqsKGGa*WW6gXCn&GlLNFaq-Ft@QGA.%]1`p$IPi2iNd4HS/e4:.sS-3E6R_o)cQEXA"bpI#QYD\\inj^A9
H%FOFkSGo?d".;:\bo=[$lM#&`K40u2`%p\GE*<,UO)5c=:if3>038-7pGunG8u_8
r$Xd9QuALADmg&Pk$.%,gGXdnUV5kKMF4O+cL0u:I/hU?"9\+'fu@'jf^Fk\A1X3d
ouPjZBQ]0LLgk.!fk8'QC8PJk'5JS"FKubN8j_kA>\T19a1hZsiWJ.*A5N'Ko_gIt
h`MlN%>UN/-,H\eEN@:W9@I'hRC+FHE[$S!S&"UAkj4
j[!`gG;q0fGBMkuI,NLUiqNN?#2@'$Un#HE8:V;n(s,5O+_--j_@R!+
6\'h8DFpAXYW6:1(a$R2gXm1knJ^D-mJ?f*D%>d(L$8%mCG0-1j85'hh"!bP1E-X*VFn$D[d=H7jnh'RX]1
H[:^?Ri_KN*mCG9F]*$bo/%ZS?Aq(X@N?[)@8A.%7@GDe_+o9;0Ue";I%9=lIGj"'
4e)hnG3XuGn=]4KKaIUm`9#r>ST+8A5OTJI>k4k)W$46W?M>BU$d/SC&](r(3486F
/gJH$6>rr^h88Qc%has3U&]MGHf_Ufm5t8'!P2/rQRZa)QqPt1dm3eMjLl(dCY#[q
O$G,a;%Ook)N6BD)s=[:D`CO)8.p!_>`C@b.:<9cb.i]3bh#)IS"M/*Y.)_R:T!-"
LRB;m1ZG+Yi'a:2;[H`kPb4Y4a?O;lKAZ:j6N\b"]8'R&`5)q'BQCX+,euRG4!%a@gCM-cGB$E+l`N
8b:A,8P?Qmq>VDV9VWjsnfj]GrcHiX:JLlJ:N]?2(bhYA!E,\)OXZSP3M;:cV#&k%f
^c<5g\c1o`"1&fb73@g_HJo8%aQeROK?e8%o,2Z/Pl!IF^fHP>_p-bm^A:FX^(hbarRmO->Rr\C3lh@WD)Or,FuH;3C$`L
RX1",Fi1=+4TsQ#LI<1T'IaeQ&"a,f,LC'#
iP]t::G(NP=kIZ):VqMV36toa5sG>3Nd-;O/;:kLMSoeU0a10]#;g,l3V^0>Pf*:u%R(\QAdWo_D24MX1rJoAFg<)'GE"i/kC!eME,0mLg
?*IAh+)mI)%IcK>]I4)PW$n^j@ra(a2>7--n=b_?K9"6bs,F+Y1mR`1gf1rE:ZVZ'
%gCdLiA]u))r#\#X7;\Aqn46+Llnb#a_C6Mbj9]:
o_*Z&)-C/-"Bja*Ub=CcA0$-\&$A5l+:0j,ic.?ihL.1mNLO,"I.
e`dtr?'A3("?#Ij>pEY*BXDjj^i&pKG?A;:)5Xa?g+sf(1[9$A5^Z\=.[Mb9poKR0
s3QfK.>uY&RM/DP^#JAOr3S7R1)3\f!*Tu!Lt]3dWd2>,_q7+bW#`Vd_\U*6uq
lO:l6,U5fFWt\]oZO1dqNOY`Zi#f;jF/fVJ4S#n6=tQ]))B(*ib(`[a&67>#s'AZc
=aQEk:8UB5-lC\@^U;+ogOEq`j6ELOn(VSKp1K;44GOhb=4mFqO17Y%#.%+rD2gZl
WueV)k4=URY8UdU9HeU/"UYF(VMJ.<.O7Ej#PaqLiu#*6iPJk%WJ!Hnq/Abi@&Va
,QW6g0Tp9F,>;f4_&fiEM7['P],''DaGKk]ouIT8jX8U_*MA&YD\AhsF,>TW*4dU!
&3k/bY\,q=OD)1J@o(Gc&N"Y$)-dZE>Pka2pZPg[:]''j*T?5$g%T>B8@sN78)\Te
P94N8fE4BmU[UCQp8FlBn[@m0:BUZ$EV1@IRP2o+cq=X3Z\_@<+=fo.Ve$i2G<#>\
UEAArI#-5\6>"L]S-2;$L?RTb@JJP-0gC$P"^D'NLm[q,V*0<`]EV58"]:!2eQ\Nf
FL15#mSO;%qIXG3gP[85SjCZs3$t+@jWO/Nh6W[=Pe9)J[N)aX$Ek-^a>FLre
lo;`B+"UK/<)Zj6Y,gZUlY+[[HQBV_hWq7gG#YPHS2u2QigZcB"d'@Y$#^iG,X=U?
+j)="(a,1NY7LaAW"d&r,=)Z8(gr3N!T3*UldR@E[UkHISsu5X1FLn!I\!grGLetT
g\]a_;2JZ1>h:$'6SE+$iHZF-pFQ@@:7r%;DU!q)+T*$B%83mZK$mO,8>hmI0iuL0<];hiF@i8_tY!_^Zi0:j/40\QH#c.a[quW
(q8Tq"4']Y,5d[".Zk^s>e*rON]V1]8"tu!A\WJHCXO0E,eaUY]Zk$!km_2j!iB:1
eUg/6W1>iAVJYi_fSqiW-Ch>URmnO7"2X[o^;RocYYrhu^@0qI;ilgC+
Fsq'cI01,tT:;4fV+H^7O.\`:\?)uh/ZC9RTq0,P^8KB(g)F5?kElbFnY9^AS>hS,
9r%(U]mgg2IP$cn]f)>_=U)$`59#6h&%H?;l\&L40<_XTZXSHe0NT+aoLQ0pC)fb0
%TRsGNY=_`bbNN(/(t1P\=J7BmQ[U>c$f!34g\R4(h2q34XmanlNstlKkN?7U@8Mb
I%$3>'e.%g+pn;)8VChgN7&J>C/t9+3mDS$"%01[;pA=/)c"m'kI1efr@GMAJf5A,
XjX25FJ_$IeOd3VgoH8!,u0PjO5NBf!aY15KFh%1'c2UDZYj&0S
Q#6p'[(NH8=\W)LL>rWPTI;0HPKh5E93PdKHA]H1do:!;RdqFeXu`b+[="!
ZO1haEF_'6?Z:VljSH2#>fPI(M54cNN9:R5?T8Ng@654&ga,2%*g)9e[c"GbG(P_-
=L6dXb3_Wm1UR$P^_b>Ci1C(Sp<<ZT9d=VKt1l\5n
:gb+a=9LP]H7u!0[-Ul3&7ENh5r&k%;)F6sL4T(A?m0OYq$:6F5jCQU+lY+5f/fNp
+UTiVlQY6f#0+Hd=5bpER):;p`aBWWULDko(krenMM2aJN7Las(^;!GlZT#3csdKW
:jZ"U8uL(q;%s6)QLu7+n8
fSa+p"Rg-$ND^_8s.kB.9RU64[ge`HlF\TRbra`oW16?-H-HmL&jlF$m?"Trg-dhW
pR_ASJK_tM-$=Ymf:6JIeO>]#I#*S,Mc-D4k*,U$#q$o6'LHV#<83Y\nRmPI$5(+h
gl)(J`%3!b6nfDcM'TS<7aj'mpj!bZfT`t?BHd/O?@j_=-H!Z*Oh;4+=NZml27
2:q"_T[6S)mDc\0UJ^k)cJ;Cj(5o_*!nTrXGQs%6crEWQV&V[m`dcuW(Zo2K9.lO)
TEulUcp>$f-c0*5='3PA"haPIb%u7N318G]1(g*JU:0P+oPZND7E2X1pS'Ds!3B7(P"4.'8NFmV8
#SVU)0m0aZm(2u%&TZ*/LE_kM(BNFN]3k6N/^-bAbF3o9:2eGqem].[FV]O\MHgF\scB,0)EXH\6t
iq"P`:QkAup"6#$jWu8B@Pn-c$#>W\(DU-'%:r$/;PV6>Uml,DNI&$1hbu=;mB(RDnGQ&-O#OY
hQda+/sSIi/ugu?)tM)Hr7[pFF@(0ATlg!!I*Aid-7tq"/s^:/4fg;EUq*>%6EX-j
>bIadk.D0=>L_&-EeAp-s8L7+*U`W'p[kre9uTs"-Z!hdp?%Wd[,-;^7p>T+0\$I)B(R'q.lmdqPpDc01"2_tBR+>h?N`_>htip/+OhBc(J7R2OVA
"Z7pV`#1+Kh,E"7M?m6s(KUW+Ue#2'![0sbB_Vu:_ahS1-tq\B,_U]!N!PPD!^VJB
UmB/Y8![0ZFA\93(\dQ8:Y4l+\A>M([:fNmrGTuOH1&6;cMRU4k>g3J2a8
ObHTI!B+&:Jo**TC#ndtD!jk*^]9&jmfU?C3rMVK#bBn6IMb_n=L]T',BT[ioa8VYD^OZH!h9aPm7A.9"6HIgPj3C-P*o()@pE]R>dLXGB\20"E,Z"C30X+W
39&j:,LaE6jQuN^m\LsOJ6e,s1c=Z7KICr[TqghB+>5LkbPTc]R@&tF\HZkT[+I$u
.qU83*$t>,?l;n*Tcb97ZIA"We#@8iB\W*3=j-ALUt@?`olk+Inc3.H"nCWQBJBZY
Q=5MDZF5ps(tZ4R`:-@S:,@9l:"?]Y^dE"-nte03T;[T2(P_Tbp.$@*&'KWh,sFa5
q@\mFpdS659.9*PbEqQs'/m3&.2u@_dMFU+2V!1B=B?_W4`W9`"@M-g5@t5!B`M`O
Z.rl2qpPKNE#e47JRc]DYuf'H=T9^l,3)(*WK`R3A=)AA?kEUM>;&XOUGSsBKl"b;
"q"X_>j$c0TW6
b^&,;=R;0h0b/;51%%/==ipLC8V)]5-VT'0L:LqP!S"OsZ&WnlIqHBo6,X>=^-pI(
RW!DX@n[ScaC3n:F"A%AjnE_FK:'KlpGO>_!33+@eiL7,DU*#Bg00^tF5aL+\IEJ@
[>5\j'.9c>&],g(QpI`301gs-Q-$D#[-Uq[r[MYh''XM<(.KSL7?m^77>q1P/(V,@
Om)cp8cSgRV2a6d@p>0;1teb]!Z!cH]l7Bf;lngh?j.LPi7K!a$!H*^G/V8VWiZPeUX%`sb5;;(2CFX:3#=]dtmR)6eCS-E[U*h3>
QN$:jh,!0)Emf?AirLkl+pp)(VP)4!lChtpoG,.V]KclN>FX09)B-4G:N'q;^DN$N
2]8F)7!EF[Toj(D.)2@j)ipYiP4I(CZEUDMBq^2N9Mt+SWDn<"(!1D^YLZs.[D$!(
TY>R[$ou4%VAihBDg#]*1TsT1*U=ZhRNMUr?cMtAeC=GWk?o&(m.eeU^QX4YJ*qrL
QQGJ5NM`bDWLpmgLW*;qG>8_PQQ*R0Pl?PPBMr&<=+cjjQI_;#Ym@-N/70Mo`Pg1M
=WA$Cn4ToK2A/6`!L,WL5-RM^+.
p>eiIO.7R*8,-[<%#us[YkP(+ou,Y)GZ,JE!!EPAdlfSG,>Io%02GSZ/j=:[#`#gB
rB?BW>7]>WEoZTYE7qep#\2#[3*^*HX@WqCdc4IUE%Je@>JWePJXgZP+CoGoMG`4=a)p+)D/V>R'n/i@TbC3D;Ho8?.i0`:ViL/4u?T
k7n2fjIa`o&&mWOe^Tk/`o^S0uZj7M6=OE@a17IcO
]EXB"bQ6)U&D7.FfXh42C:Z]l2%@"m)r;EhhqsF)pXa:b!Q[4I`+^_Hqchjm#n,Hg
Yc#5[-B@S8i]HK.0JL4Y(o9_Ac8T*_mEIZU&V]?c.N>*&\=o'@qcq6ggGi,st[8>csq
9MYq;G5K(Gr8d>Y'HAa^S[:<88/>Rs:FZ5M#`Ep`7'i5JGQYf1P]N2O2+M#R28JfW
3@7^nD@lEUa%5Q8Q`ppQ,s(1/dckkmYbX[h/j[G[-)qS(XrpMF.V7`+H3L-H'PHNX
m+gA)'qLJ:Z9Y.XU?nR:.X#'%=^<#)X-7Wr#0="A9eJ@PmQ;C*l"O;UdbSL"J<`"7
Cb*Z6>4TqB^.*#t+d:;]WWip1/LSfMq.0DkBIFS;UBO12?GD&R^P,>&>SgDS1-\Q'
WH.U\"]/3l/Q*g9OiCc3p,22h18.s?/kd'l"D(J.CdY21'KU^ti56P&/2:?1O2W"V
)1nt^=/;%ulKE4"@91UjM,(',5-jGb4:mVf)2fb1dt>(2/LteGO%A*SVMAY0G(5d
e2uoH>oJh,*778X-I\rZFc(@pBJGmuaCI22)F85_c%pRc`;A&`kFf)a7TVmF[Po3f
J"2D\)+kiXXJPaH0H.[Zqm%5(;oGZho.6NrG7H"UK0Kjqp+g4P!,r&j_;p/=OdDZs1V(7jR4,3KeUI
gn"T@s"UL2D_F`FN3M_[\1oaUX&=@5FA,q^o*A$DY.=%EQ1mcNl]trQqg/j2MNQ:1QAKi[tkPc'.jG
M:iL9T+J3Go.Ja5aCabYoC+5[/K\Pb9?\IbR`aF+_Sh'7hMZ+XKVc_
+#:5[c#,=E^(9k0C:6fuR?C9WVaseGOLn1f9IRhA4,T1EEEY#V%RhQ#UtmLZC62HL
O#)Jn.b\e6F_R@jf-ZEPE
3m<8QiTae>/5UMWX]h&++;[sREiE:Pj&7I4ZP]mkrs@!P:YF?BDi=-E[+:s/)hCIc
WaSqfEQnifGJp"@[`*L>Sh^*d4J:<_r`@JqqGeI-_K%>DQa*H"%lcTi>)SaAfVk-"
j8I<_dkT6>7R;HLGU*1`7Xg29[T6u>B68cJRf)_/:]_OO>C3"*Q#Wslo/'Q
7k_jl1DfHJLuKo&$f54dj!f9Dh#Hlf93$gu02bA6;?4F-Fj\>2LqJPb(
k@=;b?ARn^1uf^ncEJ2!3FO63H@`0pN:W2X:u:\;]N+j@r!_5."&
GaoP1$\nS*7[;dZMjfJi%_Kh[_C=\ce^VI8];@Ju#]%_c*Z&m-n9H%IL-PkEXCen\-;tj
?j]1'!eadf-T$nj!X\ro;%$Q/``lHE[bGYC/a_g8:WM.@5Bad:rgY)!3TiQOo=WE0
`KYY>$;Ucb5WrP7e5I8u17l<0f@n6gm(fHp#P`_?3QfmD6#s<`ct5,A\RkY%YjqJuhh1-cmlo-sE3I%%9TtDqqt^A]3dk5=
J>sC7PO7:jlrnuE=lTCLh;M[)8[O!_7*Bt$K)G0`]90?g`.$O3%leq)QZ1D24\)GdpU3P]#Krn*g,E[/)3LEs.0Ci!pRGH!)K
`'%b9mqC9-F\R:Q1&*gh/0Q0'm)Rb\HS`EIiYrBZY:!(qCf:m?M?i\`Ka9j"d0T[f
D8DV!gE47cb*e^1W9.u_[0uUTgD%!ug#?`Y'T&)q"e.)NI](]<^tRVCG'DK10X*Fh
4XgX?,t4UOKjP$'DUB&;1P^#?F+Dlms2R*Y$rbVH-N
%L0e^79aa&=VSis%;V0h4DV4o?>k,ClI,!H5+7>:=J[r!IdbtJpUAdZh](IX$9Q7;
`r-3aJ*\jUi#0P,pKbm_ZJc)NQ3t[eF3aAGD)pF#^egfXe&1KG<:MKbW62KK[]Efc
=B99F,Hm?3-)[0[P0Af*\C2fY4d(duQR%6:nE/As,W(`BQi:5*-4n0giYY6l@8nY2
f#0KQ;8#dZ18]?:*Xb^5B8$6k*tPTLGLnD=!jb*4a"(P/bGbh)>A.S_)\)@2GBkT@'p#l)EF&FQ57iXUFaO5"Y$jISN/+-o0Uh5`%)Y9
Y2!OU?Ko6!'6oafe^&nBIbUfqbJbqC#[!\e@ET+Out-AF@&_Ylc`BUW_3jbJ%WqA0(&^8'N>.Eu6f([A*Rf,:9rYu"K=ejuj?
jJ8%:T@ejTG+S?'P-a<:c1@N?h@kAUO51.SJ%2Yt$!d"9=1hjpD<;mImTTGti6D$>
^buAj,o=t-7+`7bP;8BU$dUN>E8:/:N
!):Bp'YVY0EV=L3FC6:5,fH#$!TMa!hS8S,qXVX8,"AfY=C*`)h$Vi+U5it(PCECW:24PM8oT$SE
8NMMPc1`$j*UuOb&K*t12Je&pPd7SSp13N0Pmig?\[>`PAqM^J4JX;,gZX)F^H_lS
-6M*5Be.`+CbK;@oUVnkiBQe$D6^Ctk)OOkT0(t
le`E68bo96mIQ(Q-]I]dJf#1X4nO#gdLr*^eM_
?cCYp`E_PRU@r=9)Ao.kqrT*/2Z5@(?dGqk9$)\MZ>4;/h`YnAmdirr:fZ6QomVA]aP^2/]R!qIr!T"lbIUo)ZO[#];7GLg_%,L^ECFA!m$/8i;iZnP-&9fpoD06lWseT
eT`U[IiZS1?bJcZ?fKU:]G4m7m,1H!_KP8OrkK;Q-6EhdDhnoLLP`>r=\2Z"A//6i
O>mmq5Rq-Gc?L(,M>kP>\Hb!Wh/U*`1!+Q!NLd6*Q@#t49U@4gU[&9gPslBg6-Sm*
a[7)TR(=*Ia$mJ(?pWmc.XG]#LW
p<`69dnZf^s#B25HdD/P3VVD!kPI^:_Ona%-_Wa.4lHY+It@fRXrK&TcRA5NEcU2t
!\WDaH`!D[N,NCG3MrW`@#ed73KIS0=&CsRP-*)30bn,AQ]g!/'>uV
o$>J%a`LOC<_giGc"69AHY\$;8Ju+*s&!3=DE=3ASNA?sB4VjX.<5@:N2L6FA]ld]4FhSf
p'?[SEHH(>c$`dtIt9iUCMXj+Gh-W0)lp@Vj
B>s@`Yi!%_=-]j'lr@+N9?tCD`l6NT)]osdpju\>c4jbi-Z8TA6lsMK,RSm\aIpb<
WIW>gQc24;3Hjc5Jd&I(%nFYHqc&H.P8Z-6Se5IkiPBc9YuFZk@nCuW`'(#5YS$G:]Z
;C;OO-.nk_6mnc(`BK;eL_qBA,D<1Je/n(3O+W#Qj0YA57A:msm$[UF^$"i34J`g2
[$W2VjP]gMki9C*6[fdW(6Ep2@@Q:+:9n7_qm_'a4Ln^k%!FlDM#h;AI]>YQZ+:X6
<0u4dOQu,N3^$d#<3=W3c"4Hf%BV4DeRh`/RADYVONU;&d`=EHfdfs(HGriC5saMp
13C&1k+Ts,>af%u$)hIfhI7Wc]*X5"6dW/5//s?KVC>5,7OTVIt0EoOZ\2G]O?/fk??9^'eGZMTE8
/_'@YmPtZZh!"P0"h>iU->\^6$U)o/&JZ_8QM:N;
8o$9nl8k38Z`QaT9B^`Qf<:CaP4&NKckD!-3ut;-+-;3^!<99f@kOQF'rO]tFU/*r%Tl&dm)P]mca/I
"OR.6gF:=1H+:Sb+7ut.Y)c8V)`0T]$dnis>B:ISdjVNO5b2&A'MJ:g#0B<@>a-j)
,9bts]IQffoAMFT[0UBd(1CRUM=T[]OaPcI`4'/qB*
-$geh9`f(uOX.[a&EK2C^6S?=*PQiQ^2db5kO5Z9;DE_GYV7FG/c?.VL1<>r9:l7barRt4aHQ_Q$H'cRejUkH+)87AB]
AihPU@(*Ggh^<%EB%(AV[+V[e]iMF"ch9k'Tj9>P&b*\*OR%W@cqfc3(@4Z&0mgU6"#TNf,GE8oJo>&7)J6s."F8YU=a3eW,@2&hGqeY;
m[>db]W1#2`J\e5;'Fr]^/%%B?f(!'3Rot7f102_52&+f9o\4_MSiJBF(>OoOt2QR
VpPnIS/3GE4arJTf]?TXdR*8/g-]V#Z--kc6tf@<+U8CJ8n%Y&ATd8#m.^PXC?8&p+R[!NN6kD`6`2q#;iHg
(E;X2",7#'<<[ZJ/4tenOUq$SMNZ.l]J)1hc1`o(6N2h0WZNqdmhqO<7`kB\P`eE6
"#KHdhYKL](e9T<"Jr;UT[`Z6lM;?>^oq1,H,)cUI'[Z/A.V-;HLhLa`k(i(j@_t7TBr/2jb"=84?GK&7EK?8;lVLWH&LbBTou)UN![oEtaaS0dm@N7KmW1=1I5m/P
rQP5Yk7l_LjrSVn!hT=\noB_)l:St`fJUIL1IL>$#2$u(O&Mt,nM6-R:('Z7`DQj"
&u'C[6b'*%,X;u-6:aFn&?]J56HG-k\:t,?>_IW`MLq'"ME4l,e7![.1X<(5=1a#n
]B2YT21PJ#s3B>6m<@rG^2LdTo:^$=-jg7\HB3\De5Q/7a?*nH`FBQSGj.UW\+!&q
-u9U^,Z(3kmnd('r'$K]_#"J*gIh$8Nm6Ds%o
G==b[07cBWb5iRlcROGHCPUDj45)PmW[8Ku7h9Q04+pXJ&b<:KSAUNr"N8GoAGCYH
4hls20.#88K^d#-,TT2Z-'A(WKMXqI+OTIAg7HX3$F8+Gq',(4P2]2R-b"Da2^m17
nKrIC4.#]78lY&_EX2D':\(ApS#p"1$Mfh3hIm_Zl/fNh79=3\7o76^TT4TgJ,Z5#
^*j*.dEEiQ)YZ:15@)=s@GE[45MVj)E;OLEYXHLqPQIp/,u'\^V]XLa:q41`fFX#i
^;Ol7Fu\dkDVr!H]m$7e4,9hMVNHf%@=7YF3lM'i[V1>Gpa/UUN)I?+NJi:A6W
2ILkO5'OYLW)"H2X5(S33L4%l)OA#duRmNObM2fi1qj=^jlVY'>"YYbDJ\s==haaZ7?iVr*'n*V-]!YlZLb&
pqgQ7Q^_rI2S[qZ:q(puTfK;*#KouD9$ZHd
PJPdAQsH0;5&c]C)`S59Q3)\,/(0@#1-9*3Q8P"-e5FMfY/cj#aoq5T$!3>Kq=8Tl
%8(De5M8GJOoadS*FI0k"+3&&E0O!7DsOflhuglp6UqDdQC2A6Ei4kfR@kI7@SZb"
8&!=GmQMs=h];R61Z4K,'TKuHdG2!*QfMn<^8)JOs,;$J"kqL-ZO*)ED<`b/1E\[A
,b-<<\1f$BZMH*[(K_>i+uQP%I69!QJ<`ErZ\jctJ]"X=[s,_ZGsb#KeRV5>;,\6B
bZ(oi5V2YS>RF/]Mkih'pO]:S(.:]8Ecn3.rCZ4+9Ij`"9[tKK6'9hT-]$h#6/WMT
?;j]o;.cr9#)Y&.1d#K_dlrecKiL@+U0:\u"87GX9cbO>?-`E4+]u&,)Ps0PoLe:@
I.$ScdYf"gou.@IY:\XZ)?2F?J&^Ug-cS:B)g?kA>,0S6V7*C,Tu0dAlbp2o=rC?k
X"BNfPGMFX>fb19(2)SRs"a,hAjW5WW@Jkt/]:shZ!`k2nJXI&/MQeS@3Y%=Z@AMJ<=_Mm1aHY&1!a3u.1`*b@ilZG"7i!T.(I7i1+]aAph3
mW",*.F[pl`@W&:Wl,N2lW'jJmagHg55rg_UH+sJosq!@JFs'\)N15/Fk
L3*UX]ACdpE0*&(+=lrB+LNZCQiW0a?*$>hW_=YbMm2HMmR/tkM=^@9u,R2hl*B
omc>"*?Oi\K-&4S2;j]\71L_dY_Nmq-!b*nMB#a'6f-W.``b#*\tOIi[.P(2ot>=m
rus0kqHHN73=j1i/%:b^^p9>jADsM8(7W5$@sf%jH32FR2X1X+6Cl=o?)G_]E^5gU
D)[#hWI6o3"I_G8.n?*W,Qt[+dju'e:8bZel,k"G5*!(Ht
W1_c,!K%`ZiRp$[aT;6Kj%&j'Z\O5lA+VdA.Tk0ZJgGp+Kbq?<[3fB]0Mbn+e
9oY-G08fDJFrWXt.M9k"'`f%IWD\UpKSEe>+mH-()#Y?q5G)TM9;RhK4=Rq)@me3K
ri0.ESZ\Qiil76Z&WPp"?Z"W>":PU#Ig34SSDjr>mBk9[,IkGHTaB#tOF1n,D+dFXgX061W3&)7FoY9#8&^&BfpYk9b^DR5#%pG7SEQ+Q3]Lqf
%%`-rJ]iXJHuZah)DscRfbTpjF<:9Y,)UoI__P;I%>>oc$:'&9(9th+978Vk85Eq`
jXkbH1^8aa$/t9*gq@EQa59TOO;N=,'k8:\/kEslI$L;o(4@'#$.Co0ec<+(PGuIT
@5](S3_ZYkCbZ!Lgf2]'FeU&p+(q,n8EUStFE(au#W4;@kqL$:.@@qa(@7A/&5/?*
Dr#_ej8S6i]jG0Mc]+RP"&$Mae1p/YA_95_p[1]_+u^(oL*.tdh]s(MQFs?TY%Y]e
G,@K&;;;9$DO3!#ZQ?lJJF9%@'ghNNPB&n_W`W6R'^SR
aWEZeB("Hd^U`7ZI.#;YrI4E9#7[W7V\dn$e03A;HITb')?Q_i02qV4;,p8h!oda2
H)OuV>,ic)8H#m-Bl?k2Af_naO^49^/8pC2;!A9dDg).720>q79[Asf06c8fdHN\E
l-"p(I:(A(qSb\I'1UZ1n_MAl`S)'gb>3g'`?@`^$RtNqIoQJ)aYO-`6DZY.-4:0<
PUJ[#V(bh%LI*n3ON!LB10"o(b>F4gm/O-\^4.Xj7lX^NjkZ_AG@ko`TW.+c`(QFO-QK!nmQ($X=L5Jdcah"<-S[D\BqC1%&K'Il,Jp<-35oY\Cq?4=Esn
7&VC1=h_8Lql(JE<`g+SID*;S#l+h-L$b;#2P=[;\I7#a-ki30F]R+Y.S.L1^nSNI9k`2fic`j
P]R`*q^Ja@"j<8L9[&EfTt+H%l@UVLPn585,_[Grfe%9Y-gRar7*:*mZ:M5uBL_4R
9">oX<-U*%5/>^O`g:5lapZBbJr,Y`K)&:O/IFpfO<(W:&]m94meJ=[V2O_5\YX+G
2/,!0_eK%p`ZF]@f_a<+)I`*1/)48dKkT]phoMY[JlCeDan)r6r$hB8?5bP>:0\af
/E_2m%&^.7O9(bT@:.">P@l6:%W35\T0GAC50,o9mr#X`qbBXKn+e-dr8@+MVpo\Z
"*G]\mYgNC]*fQ#fdWX--)4H8N?G@uge=<"D`,bJ.OMtEiCMUS@V?I6K]0ub@4]9W
AN6"g7oC"8YSgMHK:`o!7Y[;H&TH6OK]_tg`rt93G/U9_3?Z'qAs"T0^r8u?L8T[9
0T/>bJ:TBU@VK_$'fLXii%-frGo[#!7?+@1c%Odhq8FQ`0-A3S'?sX3,W(Z,a6Fg$
enZr?*5MT6=]?%I!9Y50/e,E9PQVB0)F4Y6'ZQo+[6N652d1hb$<2+:Eoc?ch6X)j*;33rsnRJ(7Tdn=b8c
BjNWl(nYke+jBjX/;7OPOV##TK/a\j#_sgS8m[K%J)m7CnR[,^J!AL#Fc)TpV4gD/`XH5I-[(,
//_P#DrlN`@F4!^`0>omB]C6K/MOhS(8Lq0k9elaZ#g-a$'4;PLp%d>fat:@_D0L,E5:UWK2ps*T<03
P/HC'PBP]X101/&;T;QG)/GLP7\(C,9h&dUH+We=U@WOK30;0IJ[L&a<2&eNA
a4Z/7$n>eOfi+MBuNY6'S"4gW;849_c7e\0226gUF?$3qo$e/V>2%@
^9[6E.9h,,Yj*]\-Jj(C^AN@n?iL&:gB$qX-IXZ>s];P:Rch8&j
^Qu$&BiLO$B9o+dp@steZl0#D9I1r#-1$_7-jlct!p%cJ)HZdo[M#DJMZACk.#01USlRt54lB_NG*n"qeM^;aiHY8kQtmkNOK*Qp2#0Y4p5
BPYVtQ,Dgo>.es^.!k\M=iu+93H2T09VGf-44h-ce-OdH%i2QBh-"qTKh/o/S't0J
H@DmV$2_60YP%V(aKF*e.'>,&=o+g`fHjK9RI9>M\cfr/6nAEB"&-Kr5`H2d(aBk@
)cfGH3#IjP!ob[n:a;q&pk\K=L63?-.(Z@0N^sG:Od'D'$0q[PC>>%VZhO1KSuKD_
S#oZWO'>np#h&
UgaE\MGj[cd-\!pLm&6>>=1;dX4iSfl/mMRc$PhU
k,@h0/Iqb!WKkii6:pqm,e5n^V$+p2Fu&1&q:IZI,D-bn;AJ@I8!TeY2,1',QJ$W#
9+a<4I)qG,";pldo_!)%n%o[V:gIGX^maO!<*'IXeQ)8hKrM$-:sGUhX?NRqp%_#\
K4$AIkH@db3ga8k(nD+ZMK9YR$51;#W!*G\QLmVD`F*lsK7$53cPo<'+;2&'>EI!**FNo%+$.>4>%3KLDH(E
LIW7'nA/)X5^KN[;?l4`5=3"O,!GM_#SlB..+(\5iaKpFBg@aW$-t19j8o:f7io&P
66oF&=pht:,Cp"@8"C@;0VM[!22H`j&2+u]*m5.ps5HH22c3/=kAl9L:0c-'JLQZ<
gt(Y5QbojK*=jU`"L`g*&b@I0O7F@FV%?Ku,a)&]8,Yh;)V!r%RpnW(c4%<[_QG.T
`s&?`"cC`=lq4!7jCeL0.GAJkA.X7WP4PL]N]_G-%.V7Lr?Md`j/7#B*)=e'&jCuc
/II+7FE5*Z-srstrHn